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ABSTRACT
The phytochemical studies on two species of Rubiaceae; Nauclea officinalis and
Nauclea subdita have been carried out. Twenty one compounds were successfully
isolated and purified using several chromatography techniques such as column
chromatography (CC), thin layer chromatography (TLC), preparative thin layer
chromatography (PTLC), and high performance liquid chromatography (HPLC). The
compounds are naucline, nauclefine, naucletine, angustine, angustoline, 3,14-
dihydroangustoline, angustidine, subditine, strictosamide, pumiloside, naucleficine,
naucleactonin C, harmane, 1,2,3,4-tetrahydro-1-oxo-β-carboline, benzamide, cinnamide,
blumenol B, blumenol A, β-sitosterol, stigmast-4-en-3-one and vanillin. Naucline and
subditine are new indole alkaloids which were isolated from the bark of Nauclea
officinalis and Nauclea subdita respectively. The structure of the isolated compounds
were elucidated using various spectroscopic methods; 1D-NMR (1H, 13C, DEPT), 2D-
NMR (COSY, HSQC, HMBC, NOESY), UV, mass spectrometry and comparison with
literature reviews. Among five compounds, subditine exhibited good cytotoxic activity
against human prostate cancer cells which are LNCaP and PC-3 with IC50 of 12.24 ±
0.19 µM and IC50 of 13.97 ± 0.32 µM respectively. IC50 values of angustoline,
angustidine, angustine and nauclefine were in the range of 58.09-149.16 µM. Subditine
showed higher selectivity against LNCaP and PC-3 prostate cancer cells than the
normal prostate cells; RWPE-1 (selectivity index: [LNCaP/PC-3] = 2.49/2/18). In
addition, ten alkaloids was tested for anticholinesterase activity. Only angustidine
showed potent inhibition with IC50 of 6.54 ± 0.37 µM on acetylcholinesterase enzyme
(AChE). On the other hand, for butyrylcholinesterae enzyme (BChE), three alkaloids
exhibited potent inhibition; angustidine, angustine and nauclefine with IC50 of 0.31 ±
0.07 µM, 1.56 ± 0.05 µM and 2.21 ± 0.03 µM, respectively. Angustidine was the most
potent inhibitor of BChE than the standard galanthamine. Enzyme kinetic studies and
iii
molecular docking suggested that the most potent compound, angustidine possess mixed
inhibition mode with inhibition constant, Ki value of 6.12 µM and its binding site was
strongest at the bottom gorge of hBChE and formed hydrogen bonding with Ser 198 and
His 438.
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ABSTRAK
Kajian fitokimia terhadap dua spesis Rubiaceae; Nauclea officinalis dan Nauclea
subdita telah dijalankan. Dua puluh satu sebatian telah berjaya diasingkan dan
ditulenkan dengan menggunakan pelbagai kaedah kromatografi seperti kromatografi
turus, kromatografi lapisan nipis, kromatografi lapisan nipis persediaan dan
kromatografi cecair prestasi tinggi. Sebatian-sebatian tersebuat ialah are naucline,
subditine, angustine, angustidine, angustoline, 3,14-dihydroangustoline, naucletine,
nauclefine, naucleficine, naucleactonin C, 1,2,3,4-tetrahydro-1-oxo-β-carboline,
harmane, cinnamide, benzamide, pumiloside, strictosamide, stigmast-4-en-3-one, β-
sitosterol, blumenol A, blumenol B dan vanillin. Naucline dan subditine merupakan
sebatian alkaloid baru yang masing-masing diasingkan daripada bahagian batang spesis
Nauclea officinalis dan Nauclea subdita. Struktur bagi sebatian yang diasingkan telah
dikenalpastikan dengan menggunakan pelbagai teknik spectroskopi; 1D-NMR (1H, 13C,
DEPT), 2D-NMR (COSY, HSQC, HMBC, NOESY), UV, mass spectrometry dan
perbandingan dengan kajian-kajian lepas. Subditine menunjukkan aktiviti sitotoksik
yang bagus terhadap kanser sel prostat manusia iaitu LNCaP dan PC3 yang masing-
masing dengan nilai IC50 12.24 ± 0.19 µM dan 13.97 ± 0.32 µM di antara lima sebatian.
Nilai IC50 bagi angustoline, angustidine, angustine dan nauclefine adalah dalam
lingkungan 58.09-149.16 µM. Subditine menunjukkan kepilihan yang lebih tinggi
terhadap kanser sel prostat manusia; LNCaP dan PC3 berbanding dengan normal sel
prostat manusia; RWPE-1 (Indeks kepilihan: [LNCaP/PC-3] = 2.49/2/18). Selain itu,
sepuluh sebatian alkaloid telah diujikan bagi aktiviti antikolinesterase. Hanya
angustidine menunjukkan potensi yang bagus bagi perencatan dengan nilai IC50 6.54 ±
0.37 µM bagi enzim asetilkolinesterase. Manakala, bagi enzim butirilkolinesterase, tiga
sebatian alkaloid menunjukkan potensi yang bagus bagi perencatan; angustidine,
angustine dan nauclefine yang masing-masing dengan IC50 0.31 ± 0.07 µM, 1.56 ± 0.05
vµM dan 2.21 ± 0.03 µM. Kajian kinetik enzim dan docking molekul mencadangkan
compound yang paling bagus potensinya, angustidine mempunyai mod jenis perencatan
campuran dengan nilai pemalar prencatan 6.12 µM dan mengikat pada bahagian bawah
“gorge” dan membentuk ikatan hidrogen Ser 198 dan His 438.
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1.1 General
Pharmaceutical importance of plants has led to the discovery and adoption of
plant extracts which are commonly used in traditional medicine.1 Therefore, there are
many medicinal plants which are being utilized as raw material sources in
pharmaceutical manufacturing. For example, two terpenoid indole alkaloids, vinblastine
1 and vincristine 2 from Catharanthus roseus, are the natural anticancer agents to be
clinically used.2,3 Regardless of developing countries or developed ones, the demand for
medicinal plants are high.
Medicinal plants have been shown to have genuine utility and a report by Okoro,
Osagie and Asibor (2010) indicated that about 80% of the rural population depend on
them as primary health care.4 In fact, Newman and Cragg (2012) estimated that
approximately 71% of the drugs that are available were either directly or indirectly
derived from plants.5
Medicinal plants exhibit various effects on living system which include
immuno-modulatory function, antiplasmodics, antioxidants, anti-inflammatory, cardio-
protective, antipyretics, analgesic and sedatives.6,7 The medicinal value of these plants
originated from the chemical substances that produce a specific physiocological action
on the human body.8 There are wide variety of plant species that have potentials to
become the source of drugs or lead compound that may be manipulated to develop
potential therapeutics for the treatment of various diseases effectively. Examples of
potent natural drugs and leads from plants are artemisinin 3 (antimalaria drug) from
Arternisia annua, demecolcine 4 (antitumor drugs) from Colchicum autumnale and
rescinnamine 5 (antihypertensive drug) from Rauvolfia serpentine. Hence, there is a
need to continue and further investigate medicinal plant’s potentials.
Malaysia has about 15,000 species of flowering plants of which around 10% of
them have medicinal properties.9,10,11 A large number of Malaysian plants possess a
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multitude of pharmacological properties. For example, Orthosiphonstamineus Benth
(Cat’s whiskers), a medicinal plants in Malaysia, possess antiapoptotic and antioxidant
activities.12
Rubiaceae is one of the plant families that is widely distributed in the Malaysian
flora with 80 genera and 555 species among which is the genus Nauclea.13 The Nauclea
genus is known to be rich in indole alkaloids. Isolation of alkaloidal constituents from N.
parva, N. latifolia, N. pobeguinii, N. diderrichii and N. orientalis have resulted in more
than 50 alkaloids which include indolopyridine alkaloids, strictosidine-related
monoterpenoid indole alkaloids and others.14 Some of these alkaloids were reported to
exert interesting biological activities such as antiproliferative (10-hydroxyangustine 6)15
and antirenin (latifoliamides C 7)16. However, very few phytochemical and biological
activity studies have been carried out on the Nauclea genus in Malaysia. In continuation
of our scientific research on plants from the Rubiaceae family, a study of the chemical
constituents of N. officinalis and N. subdita as well as evaluation on the cytotoxic and
anti-cholinesterase activities have been carried out. These activities were chosen
because alkaloids are well known to have potent cytotoxic (vinblastine and vincristine)
and anti-cholinesterase activities (galanthamine and physostigmine).
1 2
Chapter 1: Introduction
3
3 4
5
6                                                           7
Chapter 1: Introduction
4
1.2 Rubiaceae: General appearance and morphology
Rubiaceae is also known as Madder or Bedstraw and comprises 637 genera and
10,700 species worldwide.17 It is one of the fifth largest family of flowering plants (after
Orchidaceae, Compositae, Leguminosae, Gramineae). In Malaysia, it is the largest
family of trees, represented by 80 genera and 555 species of which some 244 species in
49 genres are trees.13 The most recent and complete classification based on molecular,
morphological and chemical evidence has subdivided this family into four subfamilies
which are Cinchonoideae, Ixoroideae, Antirheoideae and Rubiodeae.17,18
The Rubiaceae is an important component of the lower strata of the rain forest.
Only about a dozen species grow up to 30 m in height or taller and reaching 2 m in girth,
the commonest being Jackiopsis ornata, Metadina trichotoma, Mussaendopsis
beccariana, Nauclea officinalis, Neolamarckia cadamba and Rothmannia schoemannii.
In all, only 50 species grow taller than 10 m.
Leaves are simple, occurring opposite in two rows or decussate or in whorls. In
some taxa with one leaf reduced at successive nodes or alternate nodes or just below the
inflorescence, or both leaves reduced at alternate nodes. Secondary veins on the lower
leaf surface in some species characteristically with acarodomatia in their axils. Leaf
tissue is exceptionally with dark bacterial wart-like nodules.
Flowers are bisexual or unisexual, mostly 4 to 5 merous. Calyces free or initially
apically fused or later free or persistently fused. Sometimes with one lobe enlarged and
conspicuously coloured. Corolla variously shaped with base united in a tube and lobes
valvate or contorted in the bud .
It is free of fruits or connate into a compound fruit. It has many seeds per fruits.
The seeds are in various shape and sometimes are winged, albuminous or
exalbuminous.13
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1.3 Classification of Rubiaceae
The classification of Rubiaceae is illustrated in Scheme 1.1. It is classified into
four subfamilies which are Cinchonoideae, Ixoroideae, Antirheoideae and
Rubiodeae.17,18 The genus Nauclea is classified under the tribe of Naucleeae and
subfamily of Cinchonoideae.19
Kingdom: Plantae
Division: Magnoliophyta
Class: Magnoliopsida
Order: Rubiales
Family: Rubiaceae
Subfamily: Cinchonoideae
Ixoroideae
Antirheoideae
Rubioideae
Tribe: Naucleeae
Scheme 1.1: Classification of tribe of Rubiaceae
1.4 Medicinal uses of Rubiaceae Plants
Plants of the Rubiaceae are known to have many natural substances which have
been employed for various commercial and medicinal purposes. These plants are not
only ornamental but they are also used in African folk medicine to treat several diseases.
Based on the studies of Karou, Tchacondo, Ilboudo and Simpore (2011), more than 60
species are used for more than 70 medicinal treatments that include malaria, hepatitis,
eczema, oedema, cough, hypertension, diabetes and sexual weakness. Besides, many of
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these plants exhibited antimalarial, antimicrobial, antihypertension, antidiabetic,
antioxidant and anti-inflammatory activities through biological screening following
leads supplied by traditional healers.20
Morever, Pedersen, Gurib-Fakim, Subratty and Adsersen (1999) have carried
out in vitro antibacterial, antifungal, pharmacological tests as well as chemical
screenings on 27 plant extracts from 7 plants [Antirhea borbonica Gmel., Chassalia
coriaceae Verdc., Danais fragrans (Lam.) Pers., Gaertnera psychotrioides Baker,
Mussaenda arcuata Poiret in Lam., Mussaenda landia Poiret in Lam., Paederia foetida
L.] of the Rubiaceae. 7 out of the 27 extracts showed antibacterial properties, five
showed antifungal properties while two showed potent smooth muscle relaxation and
contractile properties.21
Morinda ellipfica, locally known as "mengkudu kecil" is a medicinal plant
which is normally used by the Malays in Peninsular Malaysia. Parts of the plant are
used to treat various health problems and ailments. Ismail (1999) had carried out
phytochemical studies on the roots of this plant that resulted in the isolation of  some
anthraquinones. The anthraquinones were subjected to a battery of bioactivity testings,
which included antimicrobial, antiviral, cytotoxicity and antioxidant assays.17 The
results indicated that some of the compounds possessed interesting biological activities
especially in the cytotoxicity and antioxidant assays. Damnacanthal and
nordamnacanthal were found to be active against many cell lines tested that may have
the potential to be developed as anticancer agents.22
Another species of Rubiaceae which also has medicinal uses is Uncaria
tomentosa or commonly known as Cat's Claw. Traditionally, the bark of this plant is
used for inflammatory arthritis and intestinal complaints such as stomach ulcers. The
alkaloids present in the bark and roots of Uncaria tomentosa have been documented to
stimulate the immune system. Studies indicate at least six of these oxindole alkaloids
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have the ability to increase immune function by up to 50% in relatively small amounts.
This finding has led to its uses around the world as an adjunctive treatment for cancer
and AIDS as well as other diseases which has negatively impact the immune
system.23,24
According to the studies by Singh and Ali (2012), 26 plant species which belong
to Rubiaceae family have been explored for their medicinal properties. The medicinal
properties of some of the plant species are listed in Table 1.125:
Table 1.1: Medicinal properties of some of the Rubiaceae species
Species Medicinal properties
Borreria articularis Linn. f. The root of this plant is used to cure stomach
pain and regulates excessive discharges
during menses, seeds have wormicide
property and is used to treat toothache.
Catunaregam nilotica Stapf. Fruits are used as safest emetic in alternative
system of medicine as well as it is used as a
remedy for diarrhea and dysentery. The roots
are frequently prescribed as paste in
headache cases.
Dentella repens Linn. The leaves are used to treat blood ailments
and to purify blood. It is also used to improve
the eyesight and is prescribed as a laxative
for constipation.
Gardenia gummifera Linn. The plant as a whole is made into a paste and
applied on bone fracture and dislocation as
fomentation to reduce pain as well as to
enhance the callus formation. In veterinary,
the paste of this plant is applied onto the
sores of cattle to repel insects. Gum released
from stem and bark is frequently used to treat
toothache, dyspepsia and to disinfect the
septic wounds. The gum is used to protect
food grains from insect and mites.
Haldina cordifolia Roxb. The bark of this plant is used as febrifuge,
antiseptic and aphrodisiac. It cures
inflammation, skin and blood diseases. The
juice of this plant is applied onto sores to kill
worms. The basal part of the stem is used as
hepato-protective treatment in jaundice and
other types of hepatitis. The root is given
after menstruation to secure the birth of a
male child.
Ixora arborea Roxb. The roots and fruits are used by the tribals to
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cure micturation and urinary problems of
females. The root bark is effective in treating
skin diseases and chest pains. The juice of the
roots and fruits is acclaimed as a cure for
nerve problems. The flowers are pounded in
fresh milk and is given to the patients to treat
whooping cough. Its areal parts are effective
in diabetes management.
Meyna spinosa Roxb. The decoction of the whole plant is used by
tribals to treat vertigo. For tetanus infection, a
decoction of the root bark is very effective.
The root is made into a paste and applied for
painful urination. The powder of the leaf is
an effective prescription to kill intestinal
worms. It is also prescribed with black
pepper to cure diphtheria. The powder of
seeds has narcotic effect.
Oldenlandia corymbosa Linn. Decoction of the plant is given in the
treatment of intermittent fever with gastric
irritation and nervous depression. The plant is
also used for treating jaundice, hepatic
diseases and as an anthelmintic. The leaves
are made into a paste and applied to cure
burning sensation of the soles and palms.
Paederia scandens Lour. The whole plant is used, mainly the leaves
and the tender twigs are used as anti arthritis,
anti-spasmodic, astringent, carminative, anti
emetic, emollient, expectorant. It is also
indicated in asthma, diarrhea, diabetes, gout
and seminal weakness. The root ash is used
to treat various skin diseases. The leaf is
made into a paste and its composition is
taken to treat leucorrhoea.
Rubia cordifolia Linn. The plant has properties like antidysentric,
anthelmintic, astringent, carminative,
expectorant and is used in cough, hepatic
obstructions, indigestion, jaundice, ulcers,
fracture, mental agony, obstructions in
urinary passage and paralytic affections. The
whole plant is used in diabetic treatment.
Decoction of the roots is given to relieve
cough, cold and respiratory problems
especially in infants. The oil extract of the
whole plant is used to cure eczema.
Chapter 1: Introduction
9
1.5 The genus Nauclea
The genus Nauclea consists of 35 species worldwide26, of which ten are
distributed throughout tropical Africa, Asia, and Australia along with one species in
China.27 The species of Nauclea include N. orientalis, N. officinalis, N. cadamba, N.
diderrichii, N. robinsonii, N. subdita, N. pobeguinii, N. gilletii, N. tenuiflora and so
on.28
These plants are usually medium to large sized trees. Its terminal vegetative bud
is strongly flattened. Stipules are ovate, or obovate, flattened to strongly keeled,
adpressed, deciduous or semi-persistent. Many flowered flowering heads in a groups of
2 to 5. Leaves are opposite, petiolate or blades chartaceous to coriaceous.29
1.6 Medicinal uses of Nauclea species
The genus Nauclea have been reported to be used for various medicinal
purposes. For example, in West and South Africa, infusions and decoctions of the stem
bark and leaves of N. latifolia are traditionally used for the treatment of malaria,
stomach aches, fever, diarrhea and nematode infections in human and animals.30 While
in Kano, Nigeria, it is used as a chewing stick and as a remedy against stomach ache
and tuberculosis.31 The Fulani in Mubi use the leaves to de-worm their cattle. On the
other hand, infusions and decoctions are used to cure malaria in Ivory Coast.32
N. orientalis is also known to have many medicinal uses. Its leaves and bark are
used medicinally against abdominal pains, animal bites and wounds.33 This plants can
also act as an anti-pyretic, vulnerary and an anti-diarrhoeic as well as in the treatment of
boils, tumors and toothaches.34
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N. officinalis, a traditional Chinese medicine, has anti-inflammatory effect and
widely used for treatment of pink eye, fever, acute jaundice and stomachache in China.
Its root, stem and branch are cut into pieces, dried and used for medical purpose.35,36,37
N. subdita, is used for the treatment of stomach ache, diabetes, skin problems
and blood pressure. Its young leaves are edible and is a source of traditional medicine to
treat stomachache.38
1.7 Nauclea officinalis
N. officinalis (Pierre ex Pitard) Merr. & Chun is a medium to big sized tree up to
30 m and 70 cm girth. The bark is smooth to cracking and shallowly fissured, greyish to
reddish brown. Its inner bark is yellow turning brown to orange on exposure. Sapwood
is in pale yellow colour while twigs is in drying dark brown colour. Leaves are elliptic
to obovate. Flowering heads are in group of 2 to 5, rarely single and each measuring 13
to 15 mm. This species is distributed throughout Malaysia, in lowlands to hill forests
and also in swampy places. They also can be found in South China, Indo-China,
Sumatra and Borneo.13
Figure 1.1: Bark of N. officinalis
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Figure 1.2: Leaves of N. officinalis
1.8 Nauclea subdita
N. subdita (Korth.) Steud is a small or medium sized tree up to 25 m in height
and 60 cm girth. The bark is smooth to fissured and cracking, sometimes scaly or
greyish brown. Its inner bark is yellow to pale brown or pink or reddish and laminated
with reddish purple layers. Sapwood is in yellow colour while twigs is in drying white
to pale brown colour. Leaves are ovate, elliptic to obovate. This species is distributed
throughout Malaysia, in lowlands to hill forests and also in swampy places and
frequently along streams and rivers. They can also be found in Northeast India and
Malesia.13
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Figure 1.3: Bark and leaves of N. subdita
Figure 1.4: Leaves of N. subdita
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1.9 Objectives of the study
The objectives of this study are:
1. To isolate chemical constituents from two Malaysian Nauclea species; N.
officinalis and N. subdita by using chromatographic methods such as column
chromatography (CC), preparative thin layer chromatography (PTLC) as well as
high performance liquid chromatography (HPLC).
2. To elucidate the structure of the isolated compounds using spectroscopic
methods such as 1D-NMR (1H, 13C and DEPT-135), 2D-NMR (COSY, HMBC,
HSQC, NOESY), Ultraviolet (UV), Infrared (IR) and LCMS-IT-TOF analysis.
3. To study the biological activities of the compounds isolated from N. officinalis
and N. subdita including anti-cancer and anti-cholinesterase activities as well
molecular docking and enzyme kinetic studies on the potent compounds.
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2.1 General
Phytochemical studies on Rubiaceae plants have produced alkaloids and non-
alkaloid constituents (e.g. triterpenes, polyphenols, fatty acids). A number of chemical
constituents have been isolated from this family especially alkaloids where their
biological activities have been investigated and reported by researchers. Indole alkaloids
in particular have diverse chemical structures and interesting biological activities. They
have been subjected to chemical and biosynthetic studies. In this chapter, the general
aspects of the indole alkaloids in terms of their classification and biogenesis will be
briefly discussed.
2.2 Alkaloids
The term alkaloid was coined in 1818 by W. Meissner and meant simply as
alkali-like. The first definition of alkaloids was given by Winterstein and Trier who
described them in a broad sense as basic, nitrogen containing compounds of either plant
or animal origin.39
A definition was given in Meyer’s Konversations-Lexikon of 1896: “Alkaloids
(plant bases) occur characteristically in plants, and are frequently distinguished by their
remarkable physiological activities. They contain carbon, hydrogen and nitrogen, and in
most cases oxygen as well; in many respects they resemble the alkalis (hence the
name)”.40
According to the IUPAC Gold Book, alkaloids are defined as basic nitrogen
containing compounds (mostly heterocyclic) occurring mostly in the plant kingdom (but
not excluding those of animal origin). Amino acids, peptides, proteins, nucleotides,
nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. By
extension, certain neutral compounds biogenetically related to basic alkaloids are
included41.
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The alkaloids are majorly distributed among flowering plants which are the
angiosperms. There have been an increase in the discovery of their occurrence in
animals, marine organisms, insects, fungi, algae and simple vascular plants over the
recent years.42,43 For example, Cai et al. (2010) had isolated two new indole alkaloids
named as arsindoline A 8 and arsindoline B 9 from the marine-derived bacterium
Aeromonas sp. CB101. In addition, Martínez-Luis, Gómez, Spadafora, Guzmán and
Gutiérrez (2012) were able to isolate anti-trypanosomal alkaloids which were 3-
hydroxyacetylindole 10, N-acetyl-β-oxotryptamine 11 and 3-formylindole 12 from the
marine bacterium, Bacillus pumilus.
8 9
10 11 12
Known Alkaloids from marine-derived bacterium
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2.3 Classification of alkaloids
Alkaloids can be classified according to biosynthetic, chemical, pharmacological
and taxonomic classification.46 Hegnauer (1963) distinguished ‘true alkaloids’ from
other nitrogen-containing metabolites on the basis of their origin from amino acids.47
He grouped the alkaloids into three types; true alkaloids, proto alkaloids and pseudo
alkaloids. The explanation for these three types of alkaloids are given below.43
I. True alkaloids
The true alkaloids are compounds containing nitrogen in a heterocyclic ring and
originate from amino acids. They are almost invariably basic. They are usually
found as a salt of an organic acid in a plant. Examples are nicotine 13 and
atropine 14. There are however some exceptions to the types of alkaloids. For
example, eventhough aristolochic acid 15 has no heterocyclic ring in its structure
while coniine48 16 is not derived from an amino acid, yet they still belong to this
group of alkaloids.
II. Proto alkaloids
The proto alkaloids are compounds which are derived from amino acids but the
amino acid nitrogen is not in a heterocyclic ring. They are basic. Their
characteristic examples are mescaline 17 and N-N-dimethyltryptamine 18.
III. Pseudo alkaloids
The pseudo alkaloids are compounds containing nitrogen in a heterocyclic ring
but they are not derived from amino acids. Their characteristic examples are
conessine 19 (steroidal alkaloids) and theobromine 20 (purines).49
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2.4 Pharmacological activities of alkaloids
Alkaloids are one of the important naturally occurring phytoconstituents.
Nowadays, many alkaloids from natural sources are commonly used as drug and a
number of alkaloidal drugs are still under clinical trial stages.
There are many well known alkaloids with pharmacological activities. For
example, physostigmine 21 from Physostigma venenosum is used as synthetic
parasympatholytic agents, cocaine 22 from Erythroxylon coca as local anesthetics and
morphine 23 from P. somniferum as analgesics.50
Another example is berberine 24 from the roots and stem-bark of Berberis
species; B.aristata, B. petiolaris, B.vulgaris, B. aquifolium, B. thunbergii and B. asiatica.
51,52,53 Berberine 24 has anti-proliferative, anti-migratory and anti-mircobial activities.54
Other examples of alkaloids with their pharmacological activities are listed in Table 2.1.
Table 2.1: Pharmacological activities of some alkaloids43
Alkaloids Source Pharmacological acitivities
Ajmalicine 25 Catharanthus roseus Hypotensive
Camptothecine 26 Camptotheca acuminata Anti-cancer
Ephedrine 27 Ephedra fragilis Spasmolytic
Quinidine 28 Remijia sp. Cardiac depressant
Quinine 29 Cinchona sp. Anti-malaria
Strychnine 30 Strychnos nux vomica CNS depressant
Codeine 31 Papaver somniferum Pain killer
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13 14
15 16
17 18
19 20
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21 21
23 24
25 26
27 28
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29 30
31 32
33 34
35
Chapter 2: General Chemical Aspect
21
2.5 Indole Alkaloids
Accroding to Atta-Ur-Rahman and Basha (1982), all indole alkaloids can be
classified into five classes; class I, class II, class III, class IV and class V, based on the
skeleton of the non-tryptophan unit. Indole alkaloids, C6C2N are derived from
tryptamine 32 (tryptophan 34) and the iridoid, secologanin 3343 to give the intermediate
of corynanthe indole, strictosidine 35. Class I indole alkaloids are derived from
secologanin 33. Skeletal rearrangement will occur after the condensation of secologanin
33 with tryptophan 34. Bond cleavage (oxidative cleavage) and the joining of a new
bond of the class I skeleton will result in the formation of the class II (Aspidosperma)
and class III (Iboga) indoles (Scheme 2.1).55,56 Class I indoles consist of corynanthe,
yohimbe and strychnos types where the yohimbe and strychnos types can be formed
through cleavage at a certain bond and the formation of a new bond, respectively
(Scheme 2.2).57
The secologanin skeleton system is no longer in its original form for class II
indole alkaloids. Bond cleavage between C-3 and C-4 has occurred and a new bond
between C-2,6 and C-4 has formed (Scheme 2.1). The third class of indole alkaloid,
class III, is formed through the same C-C bond cleavage as class II but the formation of
a new bond is between C-2,6 and C-5 instead (Scheme 2.1). The class IV indole
alkaloids consist of non-trytophan indole alkaloids, non-isoprenoid tryptophan alkaloids
and fungal (ergot) indole alkaloids while the class V indole alkaloids consist of binary
indole alkaloids. Example of indole alkaloids of the five different classes of skeletons
are shown in Table 2.2.55
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Scheme 2.1: Three major skeletal of indole alkaloids from loganin55,58
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Scheme 2.2: Various skeletal types of indole alkaloids from rearrangement of
corynanthe type (Class I)55
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Table 2.2: Biogenetic Classification of Indole Alkaloids55
Class I Alkaloids
Vincoside group
5α-carboxystrictosidine
Cadambine group
N
H
N
O
MeO2C
OH
H
OGluc
H
H
3α-dihydrocadambine
Strictosamide group
Strictosamide
Cadamine group
Cadamine
Corynantheine group
Corynantheine
Yohimbine group
Yohimbine
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Class II Alkaloids
Aspidospermine group
Vincadifformine
Apodine group
Apodine
Vincatine group
Vincatine
Kopsone group
Kopsine
Schizozygine group
Schizozygine
Cuanzine group
Cuanzine
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Class III Alkaloids
Catharanthine group
Catharanthine
Pandoline group
Pandoline
Class IV Alkaloids (not derived from secologanin)
-Non-trytophan indole alkaloids
Murrayanine group
Murrayanine
Girinimbine group
Girinimbine
Murrayazolidine group
Murrayazolidine
Mahanimbidine
Mahanimbidine
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Subincanine group
Subincanine
Couroupitine A group
Couroupitine A
-Non-isoprenoid tryptophan alkaloids
Tryptophan group
Tryptophan
Harmaline group
Harmaline
Indolopyridine
Indolopyridine ‘A’
Naufoline group
Naufoline
Nauclefine group
Nauclefine
Naulafine group
Nauclafine
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-Isoprenoid tryptophan alkaloids (fungal indole alkaloids)
Agroclavine group
Agroclavine
Neoechinuline group
Neoechinuline
Alysinopsin group
Alysinopsin
Olivacine group
Olivacine
Akaferine group
Akaferine
Aristoteline group
Aristoteline
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Class V Alkaloids (binary indole alkaloids)
I-I group
Geissospermine
I-III group
Dehydroxycopuvosine
I-III group
Capuvosidine
II-II group
Pleiomutine
II-III group
Vinblastine
III-III group
Bis-12-[11-hydroxycoronaridyl]
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2.5.1 Biosynthesis of indole alkaloid
The aromatic part of the indole alkaloids is derived from the decarboxylation of
tryptophan 34 to form tryptamine 32. This idea was suggested by Perkin and Robinson
(1919) and proved by Battersby, Burnett and Parsons (1969). The basic unit of indole
alkaloids is derived from the Mannich condensation of tryptamine 32 with an aliphatic
aldehyde (bearing nine or ten carbons) at the α or β-position of the indole nucleus to
form a Schiff base 36.61 Intramolecular attack to the imine carbon (*) through the β
carbon resulted in the formation of the indolenines 37 which then followed by a
rearrangement to form a six membered ring intermediate 38. Consecutive loss of H+ will
give the corresponding β carboline skeleton (Scheme 2.3).55
Scheme 2.3: Biosysnthetic pathway of basic structure of indole alkaloids
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Aldehyde cannot undergo a condensation reaction directly with the α-position of
the indole nucleus to form the β-carboline systems. This is shown through an
examination of reaction mechanisms where such a direct attack would generate an
intermediate 40 with a disturbed π electron cloud on the benzene ring and this kind of
intermediate would be energically unfavorable. To avoid the formation of this
intermediate, indolenine could have been formed by a β condensation to give a more
stable intermediate 39 first followed by the migration of R2 to the α-position (Scheme
2.4).55 Such pathway has been proved by Jackson and Smith (1967) with experiments.
Scheme 2.4: Formation of indolenine with favourable and unfavourable pathways
2.5.2 Biogenesis of corynanthe and yohimbe indoles
Tryptamine 32 and secologanin 33 are the precursors for the biosynthesis of
monoterpenoid indole alkaloids of classes I, II, III and V63,64,65,66. Strictosidine 35 could
be formed from the condensation of both the precursors 32 and 33 in the presence of
strictosidine synthase followed by the Pictet-Spengler reaction.67 Hence, strictosidine 36
is the important key intermediate for the biosynthesis of pyridino-indolo-
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quinolizidinone alkaloids (corynanthe type of indoles)68,69 such as angustine 42 and
yohimbe type of indoles such as yohimbine 52. For corynanthe type of indoles,
strictosidine 35 is transformed into strictosidine lactam 41 then followed by the
formation of angustine 42, angsutoline 43 and angustidine 44. Most probably the
nitrogen in the ring E (third nitrogen) could be come from the action of ammonia or
amino acid on a glucosidic precursor49 (Scheme 2.5). On the other hand, strictosidine 35
is hydrolyzed by β-glucosidase to form a reactive hemiacetal intermediate of 45 and
followed by the opening of the lactol ring to form a dialdehyde intermediate of 46. The
aldehyde group formed in 46 reacts with a secondary amine of a strictosidine
framework to produce 4,21-dehydrocorynantheine aldehyde 47. The enol 48 or keto 49
form of dehydrogeissoschizine can be produced through allylic isomerization and
enolization of 47. Delocalization of electrons of the keto form of dehydrogeissoschizine
49 forms 50 where the aldehyde in turn attacks dienamine at the γ-position to yield α-
yohimbine 51. Hydrogenation of α-yohimbine 51 lead to formation of yohimbine 52
(Scheme 2.5).
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ect33 Scheme 2.5: Proposed biosynthetic pathway of angustine 42, angustoline 43, angustidine 44
67,70 and yohimbine 5243,71
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In addition, Brown and co-workers has shown the biosynthesis of 18-19-
dihydroangustine 55 (Scheme 2.6). This indole alkaloid can be formed through initial
hydrolysis of 18,19-dihydrovincosamide 53 with a β-glucosidase enzyme followed by
the condensation with ammonia which resulted in the formation of carbinolamine 54. It
will then be transformed to 18-19-dihydroangustine 55 through oxidation using TFA as
the oxidising agent.
Scheme 2.6: Biosynthetic pathway of 18-19-dihydroangustine 5543
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3.1 General
Bark and leaves of N. officinalis and N. subdita which belong to Rubiaceae
family were studied in detail for their alkaloidal contents and other chemical
constituents. The extraction and isolation procedures of the chemical constituents from
these two species are described in chapter 6. The structures of all isolated compounds
were elucidated with various spectroscopic methods such as 1D-NMR (1H, 13C, DEPT),
2D-NMR (COSY, HSQC, HMBC, NOESY), IR, UV, LCMS-IT-TOF and also by
comparison with literature data.
3.2 Isolation and structural elucidation of chemical constituents from bark and
leaves of N. officinalis (Madek), N. officinalis (Mersing) and N. subdita
Two sets of samples of N. officinalis were studied. They were collected from
two different locations; Hutan Simpan Madek, Keluang, Johor and Hutan Simpan
Mersing, Johor. Isolation and structural elucidation of chemical constituents from the
bark of N. officinalis from both sites yieled one new compound and twelve known
compounds. The new compound isolated was identified as naucline 56 while the known
compounds were stigmast-4-en-3-one 57, vanillin 58, cinnamide 59, 1,2,3,4-tetrahydro-
1-oxo-β-carboline 60, naucletine 61, angustidine 44, benzamide 62, angustine 42,
nauclefine 63, angustoline 43, naucleficine 64 and naucleactonin C 65. Besides, the
leaves of N. offcinalis yieled seven known compounds; angustine 42, blumenol A 66,
harmane 67, 3,14-dihydroangustoline 68, pumiloside 69 and strictosamide 70 and
blumenol B 71.
Furthermore, isolation and structural elucidation of chemical constituents from
the bark of N. subdita yielded one new compound; subditine 72 and eleven known
compounds; stigmast-4-en-3-one 57, β-sitosterol 73, naucleactonin C 65, benzamide 62,
cinnamide 59, 1,2,3,4-tetrahydro-1-oxo-β-carboline 60, angustine 42, angustidine 44,
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nauclefine 63, harmane 67 and angustoline 43. In addition, two compounds; angustine
42 and harmane 67 were isolated from the leaves of N. subdita. The compounds isolated
from these three samples are summarized in Table 3.1
Chapter 3: Results and Discussion
37
Table 3.1: Summarization of compounds isolated from the three samples
No. Compounds
1 Naucline 56
2 Nauclefine 63
3 Naucletine 61
4 Angustine 42
5 Angustoline 43
6 3,14-dihydroangustoline 68
7 Angustidine 44
8 Subditine 72
9 Strictosamide 70
10 Pumiloside 69
11 Naucleficine 64
12 Naucleactonin C 65
13 Harmane 67
14 1,2,3,4-tetrahydro-1-oxo-β-carboline 60
15 Benzamide 62
16 Cinnamide 59
17 Blumenol B 71
18 Blumenol A 66
19 β-sitosterol 73
20 Stigmast-4-en-3-one 57
21 Vanillin 58
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3.2.1 Naucline 56
56
Naucline 56 was isolated as a brownish amorphous solid. The LCMS-IT-TOF
spectrum (Figure 3.2) revealed a pseudomolecular ion peak [M+H]+ at m/z 319.1450,
corresponding to the molecular formula of C20H18N2O2. UV spectrum of naucline 56
showed strong absorptions at 391, 374 and 214 nm. In the IR spectrum, an absorption
band due to a conjugated lactam carbonyl stretching vibration was observed at 1638
cm−1.72,73,74
In the 1H-NMR spectrum (Figure 3.3), the presence of four aromatic protons, a
broad peak of N-H and one -CH2-CH2-N- group were observed, suggesting a
tetrahydro-β-carboline skeleton.75 Two of the four aromatic protons in ring A appeared
as doublets at δH 7.48 and 7.33 attributable to H-9 (1H, d, J = 7.8 Hz) and H-12 (1H, d,
J = 8.2 Hz) respectively. The other as two protons, H-10 (1H, dd, J = 7.8, 7.3 Hz) and
H-11 (1H, dd, J = 7.3, 8.2 Hz), resonated at δH 7.10 and 7.21 as doublet of doublets (dd).
H-14 of ring D appeared as a singlet at δH 6.32 indicating that a double bond could be
formed between C-15 and C-16. In addition, the presence of  downfield quartet at δH
5.76 (1H, q, J = 6.6 Hz, H-19) coupled with an upfield doublet at δH 1.46 (3H, d, J = 6.6
Hz, H3-18) indicated the existence of a trisubstituted olefin group.
The 13C-NMR and DEPT spectra (Figure 3.4 and Figure 3.5) of naucline 56
indicated a total of twenty carbon signals; one methyl, one carbonyl, four methylenes,
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six methines and eight quaternary carbons. The presence of a carbonyl carbon was
observed at δC 163.1 (C-22). The signals at δC 58.9 and 66.6 could be assigned to the
resonances of two oxymethylenes, C-17 and C-21 respectively. HMBC correlations
were observed between H3-18 and C-19 (δC 125.9), H3-18 and C-20 (δC 148.0), H-19
(δH 5.76) and C-20, H-19 and C-21, established the connectivity of trisubstituted olefin
group to the pyran ring (ring E) through C-20. (Figure 3.1). The COSY spectrum
(Figure 3.6) showed correlation peaks between H2-5/H2-6 and H3-18/H-19 respectively.
Complete 1H- and 13C-NMR assignments (Table 3.2) of naucline 56 was
accomplished through analysis of COSY, HMQC, HMBC and NOESY data. Thorough
analysis of all spectral data led to the conclusion that naucline 56 is a new corynanthe
indole alkaloid. Biogenesis pathway for naucline 56 was shown in Scheme 3.1.
Figure 3.1: Selected COSY and HMBC Correlations for Naucline 56.
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Scheme 3.1: Proposed biogenesis pathway for naucline 56.
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Table 3.2: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of Naucline 56
in CDCl3.
Position 1H, δH (multiplicity, J in
Hz)
13C (δC)
NH-1 9.72 (s) -
2 - 127.4
3 - 137.9
5a
5b
3.99-4.04 (m)
4.58-4.61 (m)
40.7
6 2.92-2.98 (m) 19.5
7 - 114.4
8 - 125.6
9 7.48 (d, 7.8) 119.5
10 7.10 (dd, 7.8, 7.3) 120.5
11 7.21 (dd, 7.3, 8.2) 124.7
12 7.33 (d, 8.2) 111.9
13 - 138.5
14 6.32 (s) 102.0
15 - 136.6
16 - 125.7
17a 4.36 (br d, 12.1) 58.9
17b 4.65 (br d, 12.1)
18 1.46 (d, 6.6) 14.6
19 5.76 (q, 6.6) 125.9
20 - 148.0
21a 4.18 (br d, 11.9) 66.6
21b 4.20 (br d, 11.9)
22 - 163.1
42
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Figure 3.2: LCMS Spectrum of Naucline 56
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Figure 3.3: 1H NMR Spectrum of Naucline 56
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Figure 3.4: 13C NMR Spectrum of Naucline 56
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Figure 3.5: DEPT 135 Spectrum of Naucline 56
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Figure 3.7: HMQC Spectrum of Naucline 56
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Figure 3.8: HMBC Spectrum of Naucline 56
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Figure 3.9: NOESY Spectrum of Naucline 56
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3.2.2 Nauclefine 63
63
Nauclefine 63 was afforded as a yellowish amorphous solid. The ESIMS (Figure
3.11) showed a pseudomolecular ion peak [M+H]+ at m/z 288.1155 which was in
agreeable to the molecular formula of C18H13N3O (calc. 288.1131) with fourteen degrees
of unsaturation which consisted nine double bonds and five rings. The UV spectrum
exhibited maxima at 391, 372, 220 and 204 nm.15,76,77 The IR spectrum of nauclefine 63
showed absorption bands at 3415 and 1650 cm−1, indicative of N-H and conjugated
lactam carbonyl functionalities respectively.15,76
In the 1H-NMR spectrum (Figure 3.12), the presence of two doublets at δH 7.61
(1H, d, J = 7.9 Hz, H-9) and δH 7.42 (1H, d, J = 7.9 Hz, H-12), two triplets at δH 7.32
(1H, t, J = 7.9 Hz, H-11) and δH 7.19 (1H, t, J = 7.9 Hz, H-10), two methylenes at δH
4.53 (2H, t, J = 6.8, H2-5) and δH 3.16 (2H, t, J = 6.8, H2-6), suggesting a naucleamide
derivative with substitution pattern in ring A and C.35 Furthermore, this tetrahydro-β-
carboline skeleton (ring A, B and C)75 presence was confirmed with HMBC correlations
of H2-5 to C-3 (δC 136.7) and C-7 (δC 116.4), H2-6 to C-2 (δC 127.5) and C-7, H-9 to C-
7 and C-13 (δC 138.5) (Figure 3.10).
The 13C-NMR and DEPT spectra (Figure 3.13 and Figure 3.14) of nauclefine 63
indicated a total of eighteen carbon signals; two methylenes, eight methines, seven
quaternary carbons and one carbonyl carbon. The carbonyl of the δ lactam ring (ring D)
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resonated at δC 162.0 (C-22). In addition, the HMBC spectrum showed correlation
between H-14 (δH 6.57) and C-2, H-14 and C-3, H-5 and C-3, thus supporting the
connectivity of ring C with ring D. Furthermore, HMBC correlations of H-14 to C-20
(δC 118.6), H-17 (δH 9.57) to C-15 (δC 141.8), H-21 (δH 8.64) to C-15 and H-17 to C-21
(δC 150.9),  indicated that ring D is connected to a pyridine (ring E).
It is worth to note that nauclefine 63 is rather similar in structure with naucline
56. They differ in ring E. The ring E component in the former is actually a pyridine ring
while the latter, the ring E component is a pyran. The interesting characteristic features
of nauclefine 63 is the coupling constant value of H-20 and H-21 which is ~5Hz due to
the adjacent nitrogen atom. In addition, both H-17 and H-21 resonated very downfield
at δH 9.57 and δH 8.64, respectively.
Thorough analysis of all the spectroscopic data (Table 3.3) obtained coupled
with the literature values15,78 confirmed, without doubt, the identity of nauclefine 63.
Figure 3.10: COSY and HMBC correlations of nauclefine 63
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Table 3.3: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Nauclefine 63 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(CDCl3:CD3OD-
4:1)
Experimental
(CDCl3)
Reference*
(DMSO-d6)
NH-1 - - - -
2 - - 127.5 127.6
3 - - 136.7 137.2
5 4.53 (t, 6.8) 4.52 (t, 6.6) 40.7 40.3
6 3.16 (t, 6.8) 3.18 (t, 6.6) 19.9 19.3
7 - - 116.4 114.8
8 - - 126.1 125.4
9 7.61 (d, 7.9) 7.62 (d, 7.9) 119.9 119.7
10 7.19 (t, 7.9) 7.17 (t, 7.5) 121.0 119.9
11 7.32 (t, 7.9) 7.31 (t, 7.5) 125.3 124.5
12 7.42 (d, 7.9) 7.44 (d, 7.9) 111.7 112.0
13 - - 138.5 138.6
14 6.57 (s) 6.76 (s) 96.9 97.0
15 - - 141.8 141.6
16 - - 120.0 119.0
17 9.57 (s) 9.49 (s) 151.6 150.5
20 7.29 (d, 5.5) 7.36 (d, 5.5) 118.6 119.0
21 8.64 (d, 5.5) 8.57 (d, 5.5) 150.9 151.0
22 - - 162.0 161.1
*Literature values from Erdelmeier et al. (1992) and Abreu and Pereira (1998).
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Figure 3.12: 1H NMR Spectrum of Nauclefine 63
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Figure 3.13: 13C NMR Spectrum of Nauclefine 63
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Figure 3.15: COSY Spectrum of Nauclefine 63
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3.2.3 Naucletine 61
61
Naucletine 61 was obtained as a yellowish amorphous solid. The ESIMS (Figure
3.19) showed a pseudomolecular ion peak [M+H]+ at m/z 330.1266, corresponding to
the molecular formula of C20H15N3O2 (calc. 330.1237). The UV spectrum showed
strong absorptions at 402, 312, 260 and 210 nm.79 Naucletine 61 revealed absorption
bands at 1675 and 1653 cm−1 in IR spectrum thus indicating the presence of conjugated
carbonyl and lactam carbonyl (-NC=O) groups respectively.80
The 1H-NMR (Figure 3.20) and 13C-NMR (Figure 3.21) spectra of this alkaloid
showed a similar pattern with that of nauclefine 63 by exhibiting two doublets at δH
7.64 (1H, d, J = 8.0 Hz, H-9) and δH 7.47 (1H, d, J = 8.0 Hz, H-12) together with two
doublet of triplets (dt) at δH 7.20 (1H, dt, J = 8.0, 1.1 Hz, H-10) and δH 7.36 (1H, dt, J =
8.0, 1.1 Hz, H-11) in aromatic region. Two sets of triplets signals were also observed at
δH 4.54 (2H, t, J = 6.9 Hz) and δH 3.20 (2H, t, J = 6.9 Hz), corresponding to methylene
protons, H2-5 and H2-6 respectively. However, a marked difference between naucletine
61 and nauclefine 63 was observed in the coupling pattern of H-21. Naucletine 61
showed a singlet while nauclefine 63 revealed a doublet, therefore suggesting that C-20
is substituted. Interestingly, the former, naucletine 61, showed a methyl singlet (H3-18)
of an acetyl group at δH 2.78. A broad singlet at δH 8.89 implied the presence of an NH
unit.
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The 13C-NMR and DEPT (Figure 3.22) spectra of naucletine 61 indicated a total
of twenty carbon signals; one methyl, two methylenes, seven methines, eight quaternary
carbons and two carbonyl carbons. The carbonyl of an acetyl group resonated at δC
199.7 (C-19). In addition, the HMBC spectrum showed correlations between H-14 (δH
7.93) and C-3 (δC 138.8), H-14 and C-16 (δC 120.7), H2-5 and C-22 (δC 161.6), thus
supporting the presence of a δ lactam ring (ring D). HMBC correlations of H-14 to C-
16, H-17 (δH 9.69) to C-15 (δC 140.7) and C-16, H-21 (δH 9.23) to C-15 indicated that
ring D is attached to the pyridine (ring E). Connectivity of the acetyl group with the
pyridine forming a 3-acetylpyridine unit was revealed by the HMBC correlations of H3-
18 to C-19 and C-21 (δC 155.3) (Figure 3.18).
From the analysis of the spectroscopic data obtained (Table 3.4) and comparison
with the literature values79,81,82, thus the structure of naucletine 61 was confirmed. This
indole alkaloid has been isolated from other Rubiaceae plant such as Sarcocephalus
latifolia78 and synthesized by Ninomiya et al. (1976)
Figure 3.18: COSY and HMBC Correlations of Naucletine 61
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Table 3.4: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Naucletine 61 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(DMSO-d6)
Experimental
(CDCl3)
NH-1 8.95 (s) 11.9 (s) -
2 - - 127.3
3 - - 138.8
5 4.54 (t, 6.9) 4.39 (t, 6.9) 40.6
6 3.20 (t, 6.9) 3.12 (t, 6.9) 19.7
7 - - 116.9
8 - - 125.8
9 7.64 (d, 8.0) 7.65 (d, 8.0) 119.9
10 7.20 (dt, 8.0, 1.1) 7.07 (m) 120.9
11 7.36 (dt, 8.0, 1.1) 7.23 (m) 125.6
12 7.47 (d, 8.0) 7.45 (d, 8.1) 111.9
13 - - 138.7
14 7.93 (s) 7.73 (s) 95.4
15 - - 140.7
16 - - 120.7
17 9.69 (s) 9.41 (s) 153.9
18 2.78 (s) 2.71 (s) 29.2
19 - - 199.7
20 - - 124.7
21 9.23 (s) 9.21 (s) 155.3
22 - - 161.6
*Literature values from Lavilla et al. (1995).
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Figure 3.20: 1H NMR Spectrum of Naucletine 61
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13C NMR Spectrum of Naucletine 61
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3.2.4 Angustine 42
42
Angustine 42 was isolated as an orange amorphous solid. Its molecular formula
was confirmed as C20H15N3O from the ESIMS (Figure 3.27) which revealed a
pseudomolecular ion peak [M+H]+ at m/z 314.1361 (calc. 314.1288). In the UV
spectrum, absorption peaks at 399, 381, 305, 293 and 210 nm were observed.15 In the IR
spectrum, absorption bands were observed at 3425 and 1645 cm−1 indicated presence of
N-H and conjugated lactam carbonyl functionalities respectively.15
The signals in 1H and 13C-NMR spectra for ring A, B, C and D were very similar
to those of nauclefine 63 except the signals of ring E (fifth ring). In 1H-NMR spectrum
(Figure 3.28), H-21 (δH 8.75) resonated as a singlet implying that C-20 is substituted. In
addition, three sets of downfield signals between δH 5.56-7.13 were observed; a dd (δH
7.09, 1H, dd, J = 17.2, 11.3 Hz, H-19) and two doublets (δH 5.56, 1H, d, J = 11.3 Hz, H-
18a and δH 5.84, 1H, d, J = 17.2 Hz, H-18b). These signals signify the presence of a
vinyl group (-CH=CH2) which correlated to C-18 (δC 119.6) and C-19 (δC 130.5).
The 13C-NMR spectrum (Figure 3.29) of angustine 42 indicated a total of twenty
carbon signals; three methylenes, eight methines, eight quaternary carbons and one
carbonyl carbon. HMBC correlations of H-14 (δH 6.76) to C-16 (δC 119.7), H-17 (δH
9.50) to C-15 (δC 139.3) and C-16, H-21 (δH 8.75) to C-15, indicated that the δ lactam
ring (ring D) is fused to pyridine (ring E) through C-15 and C-16. In addition, the
HMBC spectrum showed correlations of H2-18 to C-20 (δC 127.6) and H-19 to C-21 (δC
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148.3), suggesting the vinyl group is linked to pyridine forming a 3-vinylpyridine unit
(Figure 3.26).
Complete 1H and 13C-NMR assignments (Table 3.5) were established by
thorough analysis of COSY, HMBC and HSQC data as well as reported data,15,72,73 thus
the structure of angustine 42 was established. This indole alkaloid was the major
compound in the three samples.
Figure 3.26: Selected COSY and HMBC Correlations of Angustine 42
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Table 3.5: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Angustine 42 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(CDCl3:
CD3OD
-4:1)
Experimental
(CDCl3)
Reference*
(CDCl3:
CD3OD
-4:1)
NH-1 8.68 (br s) - - -
2 - - 127.6 127.3
3 - - 136.6 137.1
5 4.54 (t, 6.5) 4.52 (t, 6.5) 40.7 40.5
6 3.18 (t, 6.5) 3.18 (t, 8.0) 19.9 19.3
7 - - 116.6 115.0
8 - - 126.2 125.2
9 7.63 (d, 8.1) 7.60 (d, 8.0) 119.9 119.1
10 7.21 (dd, 8.1, 7.0) 7.13 (t, 8.0) 121.1 119.8
11 7.34 (dd, 7.0, 8.4) 7.30 (t, 8.0) 125.5 124.4
12 7.45 (d, 8.4) 7.46 (d, 8.0) 111.8 111.5
13 - - 138.6 138.7
14 6.76 (s) 7.16 (s) 93.7 94.1
15 - - 139.3 139.8
16 - - 119.7 118.8
17 9.50 (s) 9.34 (s) 150.8 149.3
18a 5.56 (d, 11.3) 5.61 (d, 12.0) 119.6 118.8
18b 5.84 (d, 17.2) 5.89 (d, 18.0)
19 7.09 (dd, 17.2,
11.3)
7.17 (dd, 18.0, 12.0) 130.5 129.6
20 - - 127.6 127.9
21 8.75 (s) 8.66 (s) 148.3 146.4
22 - - 162.0 161.9
*Literature values from Erdelmeier et al. (1992).
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Figure 3.27: LCMS Spectrum of Angustine 42
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Figure 3.28: 1H NMR Spectrum of Angustine 42
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13C NMR Spectrum of Angustine 42
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3.2.5 Angustoline 43
43
Angustoline 43 [α] -72.7 (c 0.11, CHCl3) was obtained as an orange amorphous
solid. It has a molecular formula of C20H17N3O2 as deduced from the LCMS-IT-TOF
spectrum (Figure 3.34) which showed a pseudomolecular ion peak at m/z [M+H]+
332.1096 (calc. 332.1394). The UV spectrum showed absorption bands at 394, 375 and
210 nm.15 IR spectrum revealed absorption bands at 3282, 1653 and 1103 cm−1
suggesting the presence of O-H group, conjugated lactam carbonyl and C-O
functionalities respectively.15
The 1H and 13C-NMR spectra (Figure 3.35 and Figure 3.36) of angustoline 43 is
reminiscent with those of nauclefine 63 especially for ring A, B, C and D. The
difference is the substitution at C-20. A doublet of proton signal was observed in the
shielded region at  δH 1.44 (3H, d, J = 6.4 Hz, H3-18) and a quartet of proton signal at δH
5.21 (1H, q, J = 6.4 Hz, H-19) which correlated with the carbon signals at δC 25.0 (C-18)
and δC 65.0 (C-19) respectively in the HSQC spectrum, thus implying the presence of
hydroxyethyl moiety [–CH(OH)-CH3].
The 13C-NMR and DEPT (Figure 3.37) spectra of angustoline 43 showed a total
of twenty carbon signals; one methyl, two methylenes, eight methines, eight quaternary
carbons and one carbonyl carbon. The deshielded C-3 which is vicinally located to N-4
gave its signal at δC 137.0. The lactam carbon (C-22) resonated downfield at δC 162.0.
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H-17 and H-21 gave singlets at δH 9.90 and δH 9.26 respectively. The HMBC spectrum
showed correlations between H3-18 and C-19, H3-18 and C-20 (δC 134.8), H-19 and C-
20, H-21 and C-20 suggesting that the hydroxyethyl group is linked to pyridine (ring E)
through C-20 (Figure 3.33).
From the analysis of the spectroscopic data obtained (Table 3.6) and comparison
with the literature values,15,72,78 the structure of angustoline 43 was confirmed without
doubt.
Figure 3.33: Selected COSY and HMBC Correlations of Angustoline 43
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Table 3.6: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Angustoline 43 in C5D5N.
Position 1H
δH (multiplicity, J in Hz)
13C
δC
Experimental
(C5D5N)
Reference*
(CDCl3
:CD3OD-
4:1)
Experimental
(C5D5N)
Reference*
(CDCl3
:CD3OD-
4:1)
NH-1 - - - -
2 - - 128.9 127.5
3 - - 137.0 137.4
5 4.53 (t, 6.4) 4.51 (t, 6.6) 40.6 41.0
6 3.02 (t, 6.4) 3.19 (t, 6.6) 19.8 20.0
7 - - 115.1 115.5
8 - - 126.3 129.9
9 7.69 (d, 8.2) 7.61 (d, 8.0) 119.9 119.8
10 7.21 (dt, 8.2, 1.0) 7.16 (t, 7.5) 120.3 120.5
11 7.30 (dt, 8.2, 1.0) 7.31 (t, 7.5) 124.6 125.1
12 7.42 (d, 8.2) 7.46 (d, 8.0) 112.2 112.1
13 - - 139.7 139.3
14 7.20 (s) 7.22 (s) 94.5 95.0
15 - - 139.1 140.5
16 - - 120.0 120.0
17 9.90 (s) 9.38 (s) 150.4 150.3
18 1.44 (d, 6.4) 1.67 (d, 6.6) 25.0 23.8
19 5.21 (q, 6.4) 5.45 (q, 6.6) 65.0 66.2
20 - - 134.8 134.2
21 9.26 (s) 8.60 (s) 148.3 146.4
22 - - 162.0 162.8
*Literature values from Erdelmeier et al. (1992).
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Figure 3.34: LCMS Spectrum of Angustoline 43
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Figure 3.35: 1H NMR Spectrum of Angustoline 43
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Figure 3.37: DEPT 135 Spectrum of Angustoline 43
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Figure 3.38: COSY Spectrum of Angustoline 43
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3.2.6 3,14-dihydroangustoline 68
68
3,14-dihydroangustoline 68 [α] -88.9 (c 0.09, CHCl3) was isolated as a
yellowish amorphous solid. The LCMS-IT-TOF spectrum (Figure 3.42) displayed a
pseudomolecular ion peak at m/z [M+H]+ 334.1267, corresponding to the molecular
formula of C20H19N3O2 (calc. 334.1550) with thirteen degrees of unsaturation which
consisted eight double bonds and five rings. Its UV spectrum exhibited absorption peaks
at 393, 375 and 219 nm.15 Absorption bands at 3279, 1640 and 1101 cm−1 were
observed in IR spectrum which were due to O-H, conjugated lactam carbonyl and C-O
stretching vibration.15
Upon comparison of the 1H and 13C-NMR spectra (Figure 3.43 and Figure 3.44)
of 3,14-dihydroangustoline 68 with angustoline 43, a marked similarity was observed
except for the signals at C-3 and C-14. A broad doublet of H-3 at δH 4.95 (1H, br d, J =
12.3 Hz, H-3) and a two doublet of doublets at δH 2.81 (1H, dd, J = 16.7, 12.3 Hz, H-
14a) and at δH 3.80 (1H, dd, J = 16.7, 3.7 Hz, H-14b) which belong to two geminal
protons at C-14 were observed. Besides, the two geminal protons of H2-5 are not
equivalent and resulted in appearance of a multiplet of H-5a (δH 2.90-2.97) and a broad
doublet of H-5b (δH 5.11).
The 13C-NMR and DEPT (Figure 3.45) spectra of this alkaloid indicated a total of
twenty carbon signals; one methyl, three methylenes, eight methines, seven quaternary
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carbons and one carbonyl carbon. A carbonyl signal of a δ lactam ring was observed at
δC 163.5 (C-22). The HMBC spectrum showed correlations of H-14a with C-15 (δC
143.0), H-17 (δH 9.06) with C-15 and C-16 (δC 124.7), H-21 (δH 8.72) with C-15
suggesting the connectivity of ring D with ring E through C-15 and C-16. In addition,
HMBC correlation of H-18 (δH 1.47) with C-19 (δC 65.0) and C-20 (δC 137.2) indicated
that an hydroxyethyl group is connected to pyridine (ring E) (Figure 3.41).
The spectroscopic data obtained (Table 3.7) were consistent with those found in
the literature,15 thus confirming the identity of 3,14-dihydroangustoline 68.
Figure 3.41: COSY and HMBC Correlations of 3,14-dihydroangustoline 68
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Table 3.7: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of 3,14-
dihydroangustoline 68 in CDCl3.
Position 1H
δH (multiplicity, J in Hz)
13C
δC
Experimental
(CDCl3)
Reference*
(CDCl3:
CD3OD
-4:1)
Experimental
(CDCl3)
Reference*
(CDCl3:
CD3OD
-4:1)
NH-1 9.54 (br s) - - -
2 - - 131.8 131.6
3 4.95 (br d, 12.3) 4.96 (br, ~13) 51.3 51.3
5a 2.90-2.97
(m,overlapped)
2.98 (dt, 12.6, 4.5) 39.6 39.5
5b 5.11 (br d, 12.8) 5.13 (d, br, 12.6)
6 2.90-2.97 (m,
overlapped)
2.92 (m) 20.9 20.9
7 - - 109.4 109.6
8 - - 126.5 126.5
9 7.52 (d, 7.7) 7.54 (d, 7.8) 118.6 118.6
10 7.11 (t, 7.7) 7.14 (t, 7.8) 119.9 119.9
11 7.18 (t, 7.7) 7.20 (t, 7.8) 122.5 122.5
12 7.35 (d, 7.7) 7.37 (d, 7.8) 111.3 111.2
13 - - 136.8 137.1
14a 2.81 (dd, 16.7,
12.3)
2.86 (dd, 16.5,
13.0)
31.3 31.4
14b 3.78 (dd, 16.7, 3.7) 3.76 (dd, 16.5, 3.6)
15 - - 143.0 142.7
16 - - 124.7 124.6
17 9.06 (s) 9.08 (s) 148.6 149.3
18 1.47 (d, 6.9) 1.51 (d, 6.7) 23.9 24.0
19 5.17 (q, 6.4) 5.20 (q, 6.7) 65.0 65.2
20 - - 137.2 136.8
21 8.72 (s) 8.75 (s) 149.2 148.7
22 - - 163.5 163.4
* Literature values from Erdelmeier et al. (1992).
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Figure 3.42: LCMS Spectrum of 3,14-dihydroangustoline 68
[M+H]+
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Figure 3.44: 13C NMR Spectrum of 3,14-dihydroangustoline 68
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Figure 3.46: COSY Spectrum of 3,14-dihydroangustoline 68
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n97 Figure 3.47: HSQC Spectrum of 3,14-dihydroangustoline 68
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n98 Figure 3.48: HMBC Spectrum of 3,14-dihydroangustoline 68
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3.2.7 Angustidine 44
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Angustidine 44 was obtained as an orange amorphous solid. Its molecular
formula of C19H15N3O was determined through LCMS-IT-TOF spectrum (Figure 3.50)
which showed a pseudomolecular ion peak [M+H]+ at m/z 302.1317 (calc. 302.1288). In
the UV spectrum, absorption maxima were observed at 391, 288 and 229 nm.72 The IR
spectrum revealed absorption bands at 3401 and 1644 cm−1 for  stretching vibration of
N-H and conjugated lactam carbonyl respectively.80
The 1H and 13C-NMR spectra (Figure 3.51 and Figure 3.52) of angustidine 44
and nauclefine 63 showed a significant resemblance except for the additional methyl
singlet attached to C-21 was observed in the 1H-NMR of angustidine 44. Hence, a single
proton signal was observed at δH 7.01 (1H, s, H-20) instead of a doublet in that of
nauclefine 63. Another downfield proton at δH 9.79 was assignable to H-17. A singlet
was observed at highfield region, δH 2.47 which corresponded to carbon signal at δC
24.3 suggesting the presence of methyl group.
The 13C-NMR and DEPT (Figure 3.53) spectra of angustidine 44 showed a total
of nineteen carbon signals; one methyl, two methylenes, seven methines, eight
quaternary carbons and one carbonyl. An upfield carbon signal at δC 24.3 was attributed
to a methyl group of C-18. HMBC correlations of H3-18 (δH 2.47) to C-20 (δC 117.3)
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and C-21 (δC 161.8), H-20 with C-21 indicated that the methyl group is linked to
pyridine (ring E) through C-21 forming a 2-methylpyridine unit (Figure 3.49).
Comprehensive study of the 1D and 2D-NMR spectral (Table 3.8) and
comparison with the literature values15,72 led to the conclusion that the investigated
compound is indeed angustidine 44.
Figure 3.49: Selected COSY and HMBC Correlations of Angustidine 44
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Table 3.8: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Angustidine 44 in C5D5N.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(C5D5N)
Reference*
(CDCl3:
CD3OD-4:1)
Experimental
(C5D5N)
Reference*
(CDCl3: CD3OD
-4:1)
NH-1 11.82 (s) - -
2 - - 128.7 127.7
3 - - 137.4 137.0
5 4.49 (t, 6.9) 4.38 (t, 6.8) 40.6 40.3
6 2.98 (t, 6.9) 3.11 (t, 6.5) 19.8 19.3
7 - - 115.0 114.6
8 - - 126.3 125.5
9 7.67 (d, 8.0) 7.62 (d, 8.0) 119.9 119.7
10 7.21 (t, 8.0) 7.09 (t, 7.6) 120.3 119.9
11 7.31 (t, 8.0) 7.23 (t, 7.2) 124.6 124.4
12 7.55 (d, 8.0) 7.45 (d, 8.4) 112.3 112.0
13 - - 139.6 138.5
14 6.94 (s) 6.94 (s) 97.4 97.0
15 - - 142.5 141.9
16 - - 118.3 119.9
17 9.79 (s) 9.21 (s) 151.0 150.2
18 2.47 (s) 2.58 (s) 24.3 24.3
20 7.01 (s) 7.35 (s) 117.3 117.2
21 - - 161.8 160.2
22 - - 160.3 **145.0
* Literature values from Erdelmeier et al. (1992).
** This value may be mistakenly written. All C=O shifts of lactam signal should be more than δC160. The assignment of C-
22 of angustidine 44 was confirmed through 1D and 2D-NMR.
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Figure 3.50: LCMS Spectrum of Angustidine 44
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Figure 3.51: 1H NMR Spectrum of Angustidine 44
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Figure 3.52: 13C NMR Spectrum of Angustidine 44
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n105 Figure 3.53: DEPT 135 Spectrum of Angustidine 44
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n107 Figure 3.55: HSQC Spectrum of Angustidine 44
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3.2.8 Subditine 72
72
Subditine 72 was yielded as a yellowish amorphous solid. The LCMS-IT-TOF
spectrum (Figure 3.58) revealed a pseudomolecular ion peak [M+H]+ at m/z 330.1018,
corresponding to the molecular formula of C20H15N3O2 (calc. 330.1237). The UV
spectrum revealed absorptions at 393, 377 and 210 nm. The IR spectrum of subditine 72
showed absorption bands at 3305, 1651 and 1645 cm−1 suggested the existence of N-H,
-HC=O and conjugated -NC=O functionality.15
In the 1H-NMR spectrum (Figure 3.59), two doublets at δH 7.62 (1H, d, J = 7.8
Hz, H-9) and δH 7.47 (1H, d, J = 8.2 Hz, H-12), two dd at δH 7.34 (1H, dd, J = 8.2, 7.1
Hz, H-11) and δH 7.19 (1H, dd, J = 7.8, 7.1 Hz, H-10), two methylenes at δH 4.51 (2H, t,
J = 6.9, H2-5) and δH 3.16 (2H, t, J = 6.9, H2-6) were observed and this suggested a
naucleamide derivative with substitution pattern in ring A and C.35 Furthermore, this
tetrahydro-β-carboline skeleton (ring A, B and C)75 was indicated with HMBC
correlations of H2-5 with C-3 (δC 139.4) and C-7 (δC 117.1), H2-6 with C-2 (δC 127.3)
and C-7, H-9 and H-11 with C-13 (δC 138.7) (Figure 2). A broad singlet at δH 8.94
implied the presence of an NH unit.
The 13C-NMR and DEPT spectra (Figure 3.60 and Figure 3.61) of subditine 72
indicated a total of twenty carbon signals; one methyl, two methylene, six methine, nine
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quaternary carbon and two carbonyl. The carbonyl of the lactam ring resonated at δC
161.7 (C-22). In addition, the HMBC spectrum showed correlation between H-14 (δH
7.97) and C-3, H-14 and C-16 (δC 119.3), thus supporting the presence of a δ lactam
ring. Furthermore, HMBC correlations of H-14 with C-16 and C-20 (δC 127.6), H-17
(δH 9.57) with C-15 (δC 141.1) and C-16, H3-18 (δH 2.98) with C-21 (δC 165.9), H-19
(δH 10.72) with C-20 (δC 127.6) indicated that ring D is connected to a nicotinaldehyde
ring (ring E) with a methyl group forming a 2-methylnicotinaldehyde unit (Figure 3.57).
Subditine 72 is very similar to the known compound, angustidine 44 except that the
former has an additional carbonyl group at C-19.
Complete 1H and 13C-NMR assignments (Table 3.9) were established by
thorough analysis of COSY, HMBC, HSQC and NOESY data. Subditine 72 is a new
corynanthe indole alkaloid isolated from the bark of N. subdita. A proposed biogenesis
pathway for subditine 72 was shown in Scheme 3.2.
Figure 3.57: COSY and HMBC Correlations of Subditine 72
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Table 3.9: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Subditine 72 in CDCl3.
Position 1H (multiplicity, J in Hz) 13C (δC)
NH-1 8.94 (br s) -
2 - 127.3
3 - 139.4
5 4.51 (t, 6.9 ) 40.5
6 3.16 (t, 6.9) 19.7
7 - 117.1
8 - 125.8
9 7.62 (d, 7.8) 119.9
10 7.19 (dd, 7.8, 7.1) 120.9
11 7.34 (dd, 7.1, 8.2) 125.7
12 7.47 (d, 8.2) 111.9
13 - 138.7
14 7.97 (s) 94.7
15 - 141.1
16 - 119.3
17 9.57 (s) 155.2
18 2.98 (s) 22.6
19 10.72 (s) 192.6
20 - 127.6
21 - 165.9
22 - 161.7
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Scheme 3.2: Proposed biogenesis pathway for subditine 72.
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Figure 3.58: LCMS Spectrum of Subditine 72
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Figure 3.59: 1H NMR Spectrum of Subditine 72
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Figure 3.60: 13C NMR Spectrum of Subditine 72
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Figure 3.61: DEPT 135 Spectrum of Subditine 72
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Figure 3.62: COSY Spectrum of Subditine 72
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n118 Figure 3.63: HSQC Spectrum of Subditine 72
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n120 Figure 3.65: NOESY Spectrum of Subditine 72
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3.2.9 Strictosamide 70
70
Strictosamide 70 [α] -40.0º (c 0.1, MeOH) was isolated as a light yellowish
amorphous solid. The ESIMS (Figure 3.67) revealed a pseudomolecular ion peak
[M+Na]+ at m/z 521.1875, corresponding to the molecular formula of C26H30N2O8 (calc.
521.1894). The UV spectrum showed absorption bands at 387, 328, 225 and 203 nm.83
Stretching of conjugated lactam carbonyl and C-O groups were observed at 1653 and
1050 cm−1 respectively in its IR spectrum.83
The 1H-NMR and 13C-NMR spectra (Figure 3.68 and Figure 3.69) of this alkaloid
also showed a similar pattern with that of 3,14-dihydroangustoline 68 in aromatic region
and also the presence of two methylenes which indicating the presence of a tetrahydro-
β-carboline skeleton (ring A, B and C).75 Besides, this alkaloid showed the presence of a
δ lactam ring (ring D) with carbonyl group at position C-22 which resonated at 167.1.
From COSY spectrum (Figure 3.71), a broad doublet of methine proton, H-3, at δH 5.10
showed correlation with a pair of geminal methylene protons signal at δH 2.47-2.51 and
δH 2.07 which were assignable to H-14a and H-14b respectively. These methylene
protons also coupled with the methine proton, H-15, at δH 2.80-2.84. Furthermore,
correlation of two dd at δH 5.40 and δH 5.35 (H-18a and H-18b respectively) with an
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olefinic methine of H-19 at δH 5.68 can be observed from COSY spectrum. The geminal
protons, H2-18, showed HMBC correlation with an allylic methine carbon of C-20 at δC
44.8. H-19 also showed COSY correlation with the allylic proton H-20 (δH 2.72) which
in turn also coupled with the methine proton, H-15.
The 13C-NMR and DEPT spectra of strictosamide 70 indicated a total of twenty
six carbon signals. The carbonyl carbon of the δ lactam ring appeared at downfield
region at δC 167.1 (C-22). HMBC correlation of H-17 (δH 7.40) to C-15 (δC 25.0), C-16
(δC 109.3), C-21 (δC 98.1) and C-22, H-20 to C-15 and C-16 as well as H-21 to C-15
and C-17 (δC 149.2) indicating a 3,4-dihydro-2H-pyran ring (ring E) was attached to the
δ lactam ring (ring D) (Figure 3.66). Besides, the 13C-NMR spectrum displayed the
signal of a glucose moiety. The anomeric carbon C-1’ and H-1’ signals were observed
at δC 100.5 and δH 4.60 respectively. HMBC spectrum showed correlation of the acetal
proton H-21 at δH 5.44 (1.7 Hz) with C-1’ suggesting a glucose unit was attached to C-
21 (δC 98.1).
Strictosamide 70 has similar structure with vincosamide83. The only difference is
the stereochemistry at C-3 where strictosamide 70 has a C-3 α epimer while
vincosamide has a C-3 β epimer.84,85 The difference can be observed by comparison of
the reported data in which the chemical shift at C-5 and C-14 where it can be affected
by the coupling of H-3. C-5 and C-14 of strictosamide 70 were at δC 44.8 and δC 27.4
while those of vincosamide were at δC 41.3 and δC 32.7 respectively.84 In addition, the
configuration of C-21 was deduced to be β by the coupling constant of 7.9 Hz between
anomeric proton H-1’ and H-21.84,86,85 For an α configuration, the coupling constant
value will be around 1.2 Hz due to the difference in the dihedral angles between both
isomers.87
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From the analysis of the spectroscopic data obtained (Table 3.10) and comparison
with the literature values83,84,85, the structure of strictosamide 70 was established without
doubt.
Figure 3.66: Selected HMBC Correlations of Strictosamide 70
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Table 3.10: 1H-NMR (600 MHz) and 13C-NMR (150 MHz) Spectral Data of
Strictosamide 70 in CD3OD.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CD3OD)
Reference*
(CD3OD)
Experimental
(CD3OD)
Reference*
(CD3OD)
NH-1 - - - -
2 - - 134.8 134.8
3 5.10 (br d) 5.03 (m) 55.1 55.1
5a 4.98 (dd, 5.6, 12.5) 4.93 (dd, 5.0, 12.0) 44.8 44.7
5b 3.14 (dt, 4.6, 12.5) 3.07 (dt, 4.0, 12.0)
6a 2.95-2.97 (m) 2.93 (m) 22.1 22.1
6b 2.69-2.72 (m) 2.53-2.69 (m)
7 - - 110.3 110.3
8 - - 128.7 128.7
9 7.41 (d, 8.1) 7.37 (d, 8.1) 118.7 118.7
10 7.03 (dt, 8.1, 1.0) 6.99 (dt, 8.1, 1.0) 120.2 120.1
11 7.12 (dt, 8.1, 1.0) 7.07 (dt, 8.1, 1.0) 122.5 122.5
12 7.35 (d, 8.1) 7.32 (d, 8.1) 112.3 112.3
13 - - 137.8 137.8
14a 2.47-2.51 (m) 2.44 (m) 27.4 27.3
14b 2.07 (ddd, 13.9,
13.9, 5.9)
2.02 (ddd, 13.8,
13.8, 6.0)
15 2.80-2.84 (m) 2.79 (m) 25.0 24.9
16 - - 109.3 109.2
17 7.40 (s) 7.36 (s) 149.2 149.1
18a 5.40 (dd, 17.1, 1.7) 5.38 (dd, 16.0, 2.0) 120.5 120.5
18b 5.35 (dd, 10.2, 1.7) 5.33 (dd, 10.0, 2.0)
19 5.68 (ddd, 17.2,
10.2, 10.2)
5.64 (ddd, 17.0,
10.0, 10.0)
134.4 134.4
20 2.69-2.72 (m) 2.63-2.69 (m) 44.8 44.7
21 5.44 (d, 1.7) 5.29 (d, 2.0) 98.1 98.1
22 - - 167.1 167.1
1’ 4.60 (d, 7.9) 4.56 (d, 7.9) 100.5 100.5
2’ 2.96-2.99 (m) 2.96 (m) 74.3 74.3
3’ 3.26-3.30 (m,
overlapped) 3.16-3.34 (m)
78.3 78.2
4’ 3.19-3.22 (m) 71.4 71.4
5’ 3.26-3.30 (m,
overlapped)
78.0 77.9
6a’ 3.88 (dd, 11.9, 2.1) 3.85 (dd, 12.0, 1.9) 62.6 62.6
6b’ 3.65 (dd, 11.9, 6.1) 3.62 (dd, 12.0, 5.7)
* Literature values from Fan et al. (2010)
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Figure 3.68: 1H NMR Spectrum of Strictosamide 70
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Figure 3.69: 13C NMR Spectrum of Strictosamide 70
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Figure 3.70: DEPT 135 NMR Spectrum of Strictosamide 70
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Figure 3.71: COSY Spectrum of Strictosamide 70
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Figure 3.72: HSQC Spectrum of Strictosamide 70
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3.2.10 Pumiloside 69
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Pumiloside 69 [α] -93.5º (c 0.31, MeOH) was afforded as a light yellowish
amorphous solid. The ESIMS (Figure 3.75) displayed a pseudomolecular ion peak
[M+Na]+ at m/z 535.1649 which was in agreeable to the molecular formula of
C26H28N2O9 (calc. 535.1687) with fourteen degree of unsaturation which consisted of
eight double bonds and six rings. Interestingly, the mass of pumiloside 69 showed an
increase of 28 mass unit as compared to strictosamide 70 thus indicative the possible
presence of a carbonyl group. The UV spectrum showed absorption bands at 328, 314,
244 and 210 nm.83 The IR spectrum of pumiloside 69 showed absorption peaks at 3415
and 1653 cm−1 which indicated N-H and conjugated –NC=O stretching respectively.83
The 1H-NMR and 13C-NMR spectra (Figure 3.76 and Figure 3.77) of this alkaloid
showed very similar profile with that of strictosamide 70 including its stereochemistry.
However, in 13C-NMR spectrum, a slight difference were observed in the signals of C-6
and C-3 and the presence of an extra C=O signal at δC 173.3 (C-7). In addition, in the
1H-NMR spectrum, the presence of two d at δH 8.25 (1H, d, J = 8.1 Hz, H-9) and δH
7.71 (1H, d, J = 8.1 Hz, H-12), two dt at δH 7.63 (1H, dt, J = 8.1, 1.2 Hz, H-11) and δH
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7.35 (1H, dt, J = 8.1, 1.2 Hz, H-10) indicating the existence of aromatic system of ring
A. However, there was only one methylene at δH 4.62 (1H, dd, J = 14.2, H-5a) and δH
4.45 (1H, dd, J = 14.2, H-5b) was observed and HMBC spectrum showed correlation of
this methylene signal with C-2 (δC 151.5), C-3 (δC 60.3) and C-6 (δC 113.4), suggesting
that ring C was a five membered ring instead of six membered ring in strictodsamide 70.
The 13C-NMR spectrum of pumiloside 69 indicated a total of twenty six carbon
signals. The carbonyl of lactam ring resonated at downfield region, δC 164.5 (C-22).
HMBC spectrum showed correlation of H-9 and H-12 with another carbonyl signal C-7
suggesting the presence of quinolone unit of ring A and B (Figure 3.74).
From the analysis of the spectroscopic data obtained (Table 3.11) and comparison
with the literature values,83,84,85 the structure of pumiloside 69 was established by
possessing a quinoline instead of indole skeleton compared with strictosamide 70.
Figure 3.74: Selected HMBC Correlations of Pumiloside 69
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Table 3.11: 1H-NMR (600 MHz) and 13C-NMR (150 MHz) Spectral Data of
Pumiloside 69 in DMF-d7.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(DMF-d7)
Reference*
(CD3OD)
Experimental
(DMF-d7)
Reference*
(CD3OD)
NH-1 - - - -
2 - - 151.5 149.7
3 4.83 (br d, 12.1) 4.77 (d, 12.0) 60.3 59.4
5a 4.62 (dd, 14.2) 4.48 (dd, 14, 2.5)
47.8 47.45b 4.45 (dd, 14.2) 4.33 (d, 14)
6 - - 113.4 113.0
7 - - 173.3 173.0
8 - - 126.2 125.3
9 8.25 (d, 8.1) 8.12(d, 8.1) 125.1 124.7
10 7.35 (dt, 8.1, 1.2) 7.35(td, 8.1, 1.3) 123.1 123.2
11 7.63 (dt, 8.1, 1.2) 7.66(td, 8.1, 1.3) 131.3 131.6
12 7.71 (d, 8.1) 7.60 (d, 8.1) 119.7 118.3
13 - - 142.2 140.4
14a 2.62-2.64 (m,
overlapped)
2.50 (m) 29 28.1
14b 2.07 (q, 13.4) 2.02 (q, 12.0)
15 3.28-3.33 (m,
overlapped)
3.29 (m) 24.4 23.7
16 - - 109.7 108.9
17 7.09 (d, 2.7) 7.05 (d, 2.6) 145.4 145.1
18a 5.40 (dd, 17.1) 5.48(dd, 17, 1.5)
120.1 120.518b 5.30 (dd, 10.3) 5.35(dd, 10, 1.5)
19 5.82-5.87 (m) 5.81 (dt, 17, 10) 133.2 132.5
20 2.62-2.64 (m,
overlapped)
2.66 (dd, 9, 5) 44.7 43.6
21 5.46 (d, 1.5) 5.40 (d, 2.0) 95.9 94.8
22 - - 164.5 163.9
1’ 4.72 (d, 7.9) 4.55 (d, 7.9) 98.9 97.8
2’ 3.21-3.24 (m) 2.97-3.07 (m) 74.2 73.1
3’ 3.34-3.37 (m) 3.16-3.21 (m) 78.1 77.3
4’ 3.28-3.33 (m,
overlapped)
2.97-3.07 (m) 71.2 70.1
5’ 3.41-3.43 (m) 3.16-3.21 (m) 77.6 76.5
6a’ 3.89 (dd, 11.9) 3.70(dd, 11, 5.7) 62.2 61.1
6b’ 3.65 (q, 11.9) 3.44 (m)
* Literature values from Fan et al. (2010).
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Figure 3.75: LCMS Spectrum of Pumiloside 69
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Figure 3.77: 13C NMR Spectrum of Pumiloside 69
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Figure 3.79: HMBC NMR Spectrum of Pumiloside 69
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3.2.11 Naucleficine 64
64
Naucleficine 64 was obtained as an orange amorphous solid. It molecular
formula was confirmed as C20H14N2O2 from the ESIMS (Figure 3.81) which showed a
pseudomolecular ion peak [M+H]+ at m/z 315.1126 (calc. 315.1128). In UV spectrum,
absorption maxima were observed at 379, 364, 298, 263 and 229 nm.74 The IR spectrum
of naucleficine 64 showed absorption peaks at 3271, 1676 and 1642 cm−1, indicating the
existence of N-H, conjugated HC=O and conjugated –NC=O stretching vibrations.74
Analysis of 1H-NMR and 13C-NMR spectra (Figure 3.82 and Figure 3.83) of
naucleficine 64 showed a similar pattern with that of nauclefine 63 in the aromatic
region (two doublets and two triplets) and also the presence of two methylenes which
suggesting a tetrahydro-β-carboline skeleton (ring A, B and C).75 Both compounds also
possess the δ lactam ring D. Two other aromatic protons at δH 8.71 (1H, d, J = 7.3 Hz,
H-17), δH 7.55 (1H, t, J = 7.3 Hz, H-18) and δH 8.05 (1H, d, J = 7.3 Hz, H-19) could be
assigned to H-17 and H-19 of ring E. A broad NH singlet can be seen at δH 8.90 in 1H-
NMR spectrum.
The 13C-NMR and DEPT (Figure 3.84) spectra of naucleficine 64 indicated a
total of twenty carbon signals; two methylenes, eight methines, eight quaternary carbons
and two carbonyl carbons (Table 1). Two downfield carbon signals at δC 161.9 (C-22)
and δC 193.6 (C-21) could be assigned to carbonyl group of a δ lactam ring and an
aldehyde unit respectively. In the HMBC spectrum, correlation of H-14 (δH 8.17) to C-3
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(δC 135.3), H-5 (δH 4.54) to C-3 and C-22 (δC 161.9) can be observed, thus supporting
the connectivity of ring C with ring D (δ lactam ring). HMBC correlations of H-14 to C-
16 (δC 126.4), H-17 to C-22, H-18 to C-15 (δC 129.5) and C-16 indicating connectivity
of the δ lactam ring D with benzene ring (ring E) through C-15 and C-16. Furthermore,
the HMBC spectrum showed correlation of H-19 to C-21, H-21 (δH 10.23) to C-20
suggesting that the aldehydic moiety is linked to ring E through C-20 (Figure 3.80).
Complete 1H and 13C-NMR assignments (Table 3.12) were established by
thorough analysis of COSY, HMBC and HSQC data. From the analysis of the
spectroscopic data obtained and comparison with the literature values,74,88,89 the identity
of naucleficine 64 was ensured.
Figure 3.80: Selected COSY and HMBC Correlations of naucleficine 64
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Table 3.12: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Naucleficine 64 in CDCl3.
Position 1H
δH (multiplicity, J in Hz)
13C
δC
Experimental
(CDCl3)
Reference*
(DMSO-d6)
Experimental
(CDCl3)
Reference*
(DMSO-d6)
NH-1 8.90 (br s) 11.76 (br s) - -
2 - - 128.0 127.8
3 - - 135.3 135.0
5 4.54 (t, 6.9) 4.42 (t, 6.6) 40.9 40.4
6 3.16 (t, 6.9) 3.12 (t, 6.6) 19.9 19.1
7 - - 115.2 114.0
8 - - 126.1 125.4
9 7.57 (d, 7.8) 7.60 (d, 7.2) 119.6 119.3
10 7.17 (t, 7.8) 7.08 (t, 7.8) 120.7 119.6
11 7.31 (t, 7.8) 7.24 (t, 7.7) 125.0 124.0
12 7.46 (d, 7.8) 7.48 (d, 8.1) 111.8 111.9
13 - - 138.4 138.5
14 8.17 (s) 8.11 (s) 96.1 94.8
15 - - 129.5 129.5
16 - - 126.4 125.5
17 8.71 (d, 7.3) 8.53 (d, 7.5) 134.9 134.2
18 7.55 (t, 7.3) 7.62(t, 7.2) 125.3 125.9
19 8.05 (d, 7.3) 8.24 (d, 7.5) 141.6 138.4
20 - - 135.8 135.5
21 10.23 (s) 10.43 (s) 193.6 192.6
22 - - 161.9 160.7
*Literature values from Donfack et al. (2012).
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Figure 3.81: LCMS Spectrum of Naucleficine 64
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Figure 3.82: 1H NMR Spectrum of Naucleficine 64
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13C NMR Spectrum of Naucleficine 64
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Figure 3.84: DEPT 135 Spectrum of Naucleficine 64
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Figure 3.87: HMBC Spectrum of Naucleficine 64
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3.2.12 Naucleactonin C 65
65
Naucleactonin C 65 was yielded as a yellowish amorphous solid. The ESIMS
(Figure 3.89) displayed a pseudomolecular ion peak [M+H]+ at m/z 303.1127,
corresponding to the molecular formula of C19H14N2O2 (calc. 303.1128). Absorption
peaks at 368, 353 and 211 nm were observed in UV spectrum.83 In the IR spectrum of
naucleactonin C 65, absorption peaks at 3281 and 1653 cm−1 were revealed due to N-H
and conjugated -NC=O stretching vibrations respectively.83
In the 1H-NMR spectrum (Figure 3.90), two sets of doublets and triplets at δH
7.58 (1H, d, J = 8.0 Hz, H-9), δH 7.42 (1H, d, J = 8.0 Hz, H-12), δH 7.17 (1H, t, J = 8.0
Hz, H-10) and δH 7.30 (1H, t, J = 8.0 Hz, H-11) which represented an ortho-
disubstituted aromatic ring system together with the presence of two methylenes at δH
4.55 (2H, t, J = 6.9 Hz, H2-5) and δH 3.11 (2H, t, J = 6.9 Hz, H2-6), suggesting a
tetrahydro-β-carboline skeleton (ring A, B and C).75 In addition, two doublets and one
dd were apparent at δH 5.76 (1H, d, J = 17.9 Hz, H-18a), δH 5.40 (1H, d, J = 11.5 Hz, H-
18b) and δH 6.68 (1H, dd, J = 17.9, 11.5 Hz, H-19) respectively were attributed to C-18
(δC 116.4) and C-19 (δC 125.6), indicating the presence of a vinyl group (-CH=CH2). A
broad singlet of NH can be observed at δH 8.46.
The 13C-NMR spectrum (Figure 3.91) of naucleficine 64 indicated a total of
nineteen carbon signals; three methylenes, seven methines, eight quaternary carbons and
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one carbonyl carbon. A downfield carbon signal was observed at δC 153.6 which could
be assigned to carbonyl group of a δ lactam ring (C-22). The proof that H-21 belongs to
the deshielded five membered furan ring is from the 13C signal of C-21 due to the
electronegative effect of the vicinal O-17. However, H-21 resonated at higher field due
to steric hindrance effect which is confirmed in many furan system.90 HMBC
correlations of H-14 (δH 6.78) to C-16 (δC 143.5), H-21 (δH 7.74) to C-15 (δC 130.3) and
C-16 indicated that ring D is connected to the furan ring (ring E). In addition, the
attachment of the vinyl group with the furan ring forming a vinylfuran unit through C-
20 was suggested by the HMBC correlation of H2-18 to C-20 (Figure 3.88).
Based on the available spectral data (Table 3.13) and investigation of the literature
values,83 the structure of naucleactonin C 65 was confirmed.
Figure 3.88: Selected COSY and HMBC Correlations of Naucleactonin C 65
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Table 3.13: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Naucleactonin C 65 in CDCl3.
Position 1H
δH (multiplicity, J in Hz)
13C
δC
Experimental
(CDCl3)
Reference*
(DMSO-d6)
Experimental
(CDCl3)
Reference*
(DMSO-d6)
NH-1 8.46 (br s) 11.67 (s) - -
2 - - 128.3 128.5
3 - - 133.5 133.6
5 4.55 (t, 6.9) 4.40 (t, 6.7) 40.8 40.1
6 3.11 (t, 6.9) 3.07 (t, 6.7) 19.9 19.1
7 - - 113.9 111.9
8 - - 126.3 125.4
9 7.58 (d, 8.0) 7.59 (d, 8.0) 119.5 119.1
10 7.17 (t, 8.0) 7.07 (td, 8.0, 1.0) 120.8 119.4
11 7.30 (t, 8.0) 7.22 (td, 8.0, 1.0) 124.4 123.4
12 7.42 (d, 8.0) 7.42 (d, 8.0) 111.6 111.5
13 - - 137.9 137.8
14 6.78 (s) 7.33 (s) 93.2 93.3
15 - - 130.3 129.7
16 - - 143.5 142.5
18a 5.76 (d, 17.9) 5.97 (d, 18.0) 116.4 116.1
18b 5.40 (d, 11.5) 5.47 (d, 11.0)
19 6.68 (dd, 17.9,
11.5)
6.80 (dd, 18.0,
11.0)
125.6 125.9
20 - - 120.6 119.9
21 7.74 (s) 8.23 (s) 146.2 147.5
22 - - 153.6 152.4
* Literature values from Fan et al. (2010).
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Figure 3.89: LCMS Spectrum of Naucleactonin C 65
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Figure 3.90: 1H NMR Spectrum of Naucleactonin C 65
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13C NMR Spectrum of Naucleactonin C 65
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Figure 3.93: HSQC Spectrum of Naucleactonin C 65
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Figure 3.94: HMBC Spectrum of Naucleactonin C 65
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3.2.13 Harmane 67
67
Harmane 67 was isolated as a brownish amorphous solid. It has a molecular
formula of C12H10N2 as deduced from the ESIMS (Figure 3.96) which showed a
pseudomolecular ion peak at m/z [M+H]+ 183.0942 (calc.183.0917). In UV spectrum,
the absorption peaks at 348, 288, 233 nm were observed.91 The IR spectrum of harmane
67 showed a broad absorption band at 3145 cm−1 indicated the presence of N-H group
of indole alkaloid.
In the 1H-NMR spectrum (Figure 3.97), proton signals at the aromatic regions of
δH 8.10 (1H, d, J = 8.0 Hz, H-5), δH 7.52-7.57 (1H, m, overlapped, H-8), δH 7.52-7.57
(1H, m, overlapped, H-7), δH 7.27 (1H, m, H-6) and two downfield methine signals at δH
8.34 (1H, t, J = 5.4, H-3) and δH 7.81 (1H, t, J = 5.4, H-4), suggesting the presence of β-
carboline skeleton.92 COSY correlation between H-3 and H-4, H-5 and H-6, H-7 and H-
6 were observed. A broad singlet at δH 8.80 could be assigned to NH.
The 13C-NMR and DEPT spectra (Figure 3.98 and Figure 3.99) of harmane 67
indicated a total of twelve carbon signals; one methyl, six methines and five quaternary
carbons. An upfield methyl signal of H3-1’ at δH 2.81 correlated with two quaternary
carbon of C-9a (δC 134.7) and C-1 (δC 141.8), indicating a methyl unit was attached to
the β-carboline skeleton (Figure 3.95).
From the analysis of the spectroscopic data obtained (Table 3.14) and comparison
with the literature values,92,93 the structure of harmane 67 was confirmed.
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Figure 3.95: Selected COSY and HMBC Correlations of Harmane 67
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Table 3.14: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Harmane 67 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(CDCl3)
Experimental
(CDCl3)
Reference*
(CDCl3)
1 - - 141.8 141.8
3 8.34 (d, 5.4) 8.37 (d, 5.2) 138.4 138.8
4 7.81 (d, 5.4) 7.83 (d, 5.5) 113.1 112.9
4a - - 128.5 128.3
4b - - 122.0 122.1
5 8.10 (d, 8.0) 8.12 (d, 8.0) 121.9 121.8
6 7.27 (m) 7.29 (dt, 6.9,
2.2)
120.0 120.2
7 7.52-7.57 (m,
overlapped)
7.54 (m) 128.4 128.2
8 7.52-7.57 (m,
overlapped)
7.54 (m) 111.7 111.6
8a - - 140.3 140.1
NH-9 8.80 (br s) 8.62 (br s) - -
9a - - 134.7 134.6
1’ 2.81 (s) 2.84 (s) 20.2 20.4
*Literature value from Seki et al. (1993).
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Figure 3.96: LCMS Spectrum of Harmane 67
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Figure 3.97: 1H NMR Spectrum of Harmane 67
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13C NMR Spectrum of Harmane 67
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Figure 3.99: DEPT 90 Spectrum of Harmane 67
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3.2.14 1,2,3,4-tetrahydro-1-oxo-β-carboline 60
60
1,2,3,4-tetrahydro-1-oxo-β-carboline 60 was afforded as a brownish amorphous
solid. The LCMS-IT-TOF spectrum (Figure 3.104) displayed a pseudomolecular ion
peak [M+H]+ at m/z 187.9447, corresponding to the molecular formula of C11H10N2O
(calc. 187.0866). In UV spectrum, absorption maxima of this alkaloid at 298 and 240
nm were observed.94 In IR spectrum, absorption peaks at 3415 and 1734 cm−1 were
observed due to N-H and C=O stretching respectively.94
In the 1H-NMR spectrum (Figure 3.105), the presence of two doublets at δH 7.61
(1H, d, J = 8.2 Hz, H-5) and δH 7.45 (1H, d, J = 8.2 Hz, H-8), two dt at δH 7.33 (1H, dt,
J = 8.2, 0.9 Hz, H-7) and δH 7.17 (1H, dt, J = 8.2, 0.9 Hz, H-6), two methylenes at δH
3.73 (1H, dt, J = 2.6, 7.1 Hz, H-3) and δH 3.68 (1H, t, J = 7.1, 14.0 Hz, H-4), suggesting
a tetrahydro-β-carboline skeleton (ring A, B and C)75. This skeleton can also be
indicated by HMBC correlations of H-4 to C-4b (δC 119.9) and C-9a (δC 126.2), H-5 to
C-7 (δC 125.3) and C-8a (δC 137.1), H-7 to C-8a (Figure 3.103). Two broad singlet can
be observed at δH 9.11 and δH 5.66 which were assigned to NH-9 and NH-2
respectively.
The 13C-NMR spectrum (Figure 3.106) of 1,2,3,4-tetrahydro-1-oxo-β-carboline
60 indicated a total of eleven carbon signals; two methylenes, four methines, four
quaternary carbons and one carbonyl carbon. A downfield carbonyl signal resonated at
δC 162.8 (C-1). HMBC correlation of H-3 to this carbonyl signal suggesting the
presence of oxo-β-carboline skeleton.
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Based on the spectral data obtained (Table 3.15) and comparison with literature
values,94 the structure of 1,2,3,4-tetrahydro-1-oxo-β-carboline 60 was confirmed
without doubt.
Figure 3.103: Selected COSY and HMBC Correlations of 1,2,3,4-tetrahydro-1-
oxo-β-carboline 60
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Table 3.15: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of 1, 2,
3, 4-tetrahydro-1-oxo-β-carboline 60 in CDCl3.
Position 1H
δH (multiplicity, J in Hz)
13C
δC
Experimental
(CDCl3)
Reference*
(CDCl3)
Experimental
(CDCl3)
Reference*
(CDCl3)
1 - - 162.8 163.1
NH-2 5.66 (br s) 5.76 (s) - -
3 3.73 (dt, 2.6, 7.1) 3.71 (dt, 2.7, 7.3) 42.2 42.3
4 3.08 (t, 7.1, 14.0) 3.06 (t, 6.8, 14.2) 20.8 20.9
4a - - 125.3 126.2
4b - - 119.9 120.0
5 7.61 (d, 8.2) 7.45 (d, 8.2) 120.4 120.4
6 7.17 (dt, 8.2,0.9) 7.15 (dt, 0.9, 7.2) 120.3 120.4
7 7.33 (dt, 8.2, 0.9) 7.31 (dt, 0.8, 6.9) 125.3 125.3
8 7.45 (d, 8.2) 7.58 (d, 8.2) 112.3 112.5
8a - - 137.1 137.2
NH-9 9.11 (br s) 9.26 (s) - -
9a - - 126.2 126.2
*Literature value from Fadaeinasab et al. (2013).
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Figure 3.104: LCMS Spectrum of 1, 2, 3, 4-tetrahydro-1-oxo-β-carboline 60
C
h
apter
 3:
 R
esults
 a
nd
 D
iscu
ssio
n172
C
h
apter
 3:
 R
esults
 a
nd
 D
iscu
ssio
n172
C
h
apter
 3:
 R
esults
 a
nd
 D
iscu
ssio
n173
Figure 3.105: 1H NMR Spectrum of 1, 2, 3, 4-tetrahydro-1-oxo-β-carboline 60
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Figure 3.106: 13C NMR Spectrum of 1, 2, 3, 4-tetrahydro-1-oxo-β-carboline 60
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Figure 3.107: COSY Spectrum of 1, 2, 3, 4-tetrahydro-1-oxo-β-carboline 60
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n176 Figure 3.108: HSQC Spectrum of 1, 2, 3, 4-tetrahydro-1-oxo-β-carboline 60
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n177 Figure 3.109: HMBC Spectrum of 1, 2, 3, 4-tetrahydro-1-oxo-β-carboline 60
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3.2.15 Benzamide 62
62
Benzamide 62 was obtained as light yellowish amorphous solid. Its molecular
formula was confirmed as C7H7NO from the ESIMS (Figure 3.111) which revealed a
pseudomolecular ion peak [M+H]+ at m/z 122.0601 (calc. 122.0600). In its UV
spectrum, absorption bands of this compound at 222 nm were observed.95 The IR
spectrum showed absorption peaks at 3390 and 3187 cm−1, indicating the presence of
NH2 group. The peak at 1615 cm−1 indicated conjugated carbonyl stretching
vibrations.95,96
In the 1H-NMR spectrum (Figure 3.112), the overlapping proton signals in
aromatic region were observed as two sets of doublets and three sets of triplets
suggested the presence of mono-substituted aromatic ring. H-3 was overlapped with H-7
at δH 7.80-7.82 (2H, d, J = 7.4 Hz) and appeared as doublet peak while H-4 was
overlapped with H-6 at δH 7.43-7.47 (2H, t, J = 7.4 Hz) and appeared as triplet peak.
Doublet of H-5 resonated at δH 7.53 (1H, d, J = 7.4 Hz). Furthermore, a broad doublet
was observed at δH 6.01 which attributed to NH2 group.
The 13C-NMR and DEPT spectral (Figure 3.113 and Figure 3.114) of benzamide
62 showed a total of seven carbon signals; five methines, one quaternary carbon and one
carbonyl carbon. A carbonyl signal resonated at downfield region δC 169.7 (C-1).
Overlapped carbon signals of C-4 and C-6, C3 and C-7 at δC 128.8 and δC 127.5
respectively were due to equivalent environment in the aromatic ring. Connectivity of
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the aromatic ring with an amide group was shown through HMBC correlation of H-3
and H-7 with carbonyl group of C-1 (Figure 3.110).
From the analysis of the spectroscopic data obtained (Table 3.16) and
comparison with the literature values,96 the structure of benzamide 62 was confirmed.
Figure 3.110: COSY and HMBC Correlations of Benzamide 62
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Table 3.16: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Benzamide 62 in CDCl3.
Position 1H
δH (multiplicity, J in Hz)
13C
δC
Experimental
(CDCl3)
Reference*
(CDCl3)
Experimental
(CDCl3)
Reference*
(CDCl3)
NH2 6.01 (br d) - - -
1 - 169.7 169.9
2 - - 132.9 133.3
3 7.80-7.82 (d, 7.4) **7.39-7.43 (m) 127.5 **128.5
4 7.43-7.47 (t, 7.4) **7.78-7.80 (m) 128.8 **127.3
5 7.53 (t, 7.4) 7.47-7.51 (m) 132.3 132.0
6 7.43-7.47 (t, 7.4) **7.78-7.80 (m) 128.8 **127.3
7 7.80-7.82 (d, 7.4) **7.39-7.43 (m) 127.5 **128.5
* Literature value from Saidi (2010).
** The chemical shifts were interchangeable. Experimental values were confirmed through 1D and 2D-NMR.
C
h
apter
 3:
 R
esults
 a
nd
 D
iscu
ssio
n181 Figure 3.111: LCMS Spectrum of Benzamide 62
C
h
apter
 3:
 R
esults
 a
nd
 D
iscu
ssio
n182
Figure 3.112: 1H NMR Spectrum of Benzamide 62
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13C NMR Spectrum of Benzamide 62
C
h
apter
 3:
 R
esults
 a
nd
 D
iscu
ssio
n184 Figure 3.114: DEPT Spectrum of Benzamide 62
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Figure 3.116: HSQC Spectrum of Benzamide 62
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n187 Figure 3.117: HMBC Spectrum of Benzamide 62
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3.2.16 Cinnamide 59
59
Cinnamide 59 was yielded as a light yellowish amorphous solid. The ESIMS
(Figure 3.118) showed a pseudomolecular ion peak [M+H]+ at m/z 148.0750,
corresponding to the molecular formula of C9H9NO (calc. 148.0757). In UV spectrum,
absorption bands of compound at 272 and 217 nm were observed. The IR spectrum of
cinnamide 59 showed absorption peaks at 3369 and 3172 cm−1 indicating the presence
of NH2 group while 1655 cm−1 was due to carbonyl stretching vibrations.96
In the 1H-NMR spectrum (Figure 3.119), the overlapped proton signals at δH
7.52-7.53 (2H, m, H-2 and H-6) and δH 7.38-7.39 (3H, m, H-3, H-4 and H-5) indicating
the presence of mono-substituted aromatic ring. The doublets proton signals at δH 6.46
(1H, d, J = 15.7, H-7) and δH 7.66 (1H, d, J = 15.7, H-8) with coupling constant of 15.7
Hz suggesting the presence of a trans-substituted double bond.
The 13C-NMR spectrum (Figure 3.120) of cinnamide 59 indicated a total of nine
carbon signals; seven methines, one quaternary carbon and one carbonyl carbon. A
downfield carbonyl signal resonated at δC 167.6 (C-9). The carbon signal for C-8 (δC
119.3) appeared more upfield than that C-7 (δC 142.7) due to the resonance effect
caused by the vicinal C=O group.
From the analysis of the spectroscopic data obtained (Table 3.17) and
comparison with the literature values,96 the structure of cinnamide 59 was confirmed.
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Table 3.17: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Cinnamide 59 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(CDCl3)
Experimental
(CDCl3)
Reference*
(CDCl3)
1 5.56 (br d) - 134.5 134.4
2 7.52-7.53 (m) 7.47-7.49 (dd, 9.2, 3.9) 127.9 127.8
3 7.38-7.39 (m) 7.33-7.34 (m) 128.9 128.7
4 7.38-7.39 (m,
overlapped)
7.33-7.34 (m) 130.0 129.8
5 7.38-7.39 (m) 7.33-7.34 (m) 128.9 128.7
6 7.52-7.53 (m) 7.47-7.49 (dd, 9.2, 3.9) 127.9 127.8
7 7.66 (d, 15.7) 7.59-7.63 (d, 15.6) 142.7 **129.3
8 6.46 (d, 15.7) 6.47-6.49 (d, 15.6) 119.3 **142.2
9 - 167.6 168.8
* Literature value from Saidi (2010)
**The chemical shifts were interchangeable. Experimental values were confirmed through 1D and 2D-NMR
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Figure 3.118: LCMS Spectrum of Cinnamide 59
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1H NMR Spectrum of Cinnamide 59
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Figure 3.120: 13C NMR Spectrum of Cinnamide 59
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Figure 3.121: COSY Spectrum of Cinnamide 59
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Figure 3.122: HSQC Spectrum of Cinnamide 59
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3.2.17 Blumenol B 71
71
Blumenol B 71 [α] +36.4º (c 0.11, CHCl3) was isolated as a white amorphous
solid. It has a molecular formula of C13H22O3 as deduced from the ESIMS (Figure
3.124) which displayed a pseudomolecular ion peak at m/z [M+H]+ 227.1733 (calc.
227.1642). UV spectrum exhibited absorption maxima at 242 nm.97 The IR spectrum of
showed absorption peaks at 3401, 1651 and 1126 cm−1, indicating the presence of OH,
C=O and  C-O stretching vibrations.97
In the 1H-NMR spectrum (Figure 3.125), a methyl group resonated as a doublet
at δH 1.22 (J = 6.0) which could be assigned to H-10. This methyl proton was coupled
with H-9 which gave a signal as multiplet at δH 3.75-3.81. In addition, two singlets
corresponding to six protons of two methyls (H3-11 and H3-12) appeared at δH 1.08 and
δH 1.04 respectively. Furthermore, another methyl group (δH 2.04, H3-13) attached to C-
5 gave a fine doublet with a coupling constant of 0.9 Hz due to the long range coupling
with H-4. One set of doublet (δH 2.33 and δH 2.48) and two sets of multiplets (δH 1.94-
1.99 and δH 1.79-1.89, δH 1.58-1.67 and δH 1.47-1.56) may be attributed to the
methylene groups H2-2, H2-7 and H2-8 respectively.
The 13C-NMR and DEPT spectra (Figure 3.126 and Figure 3.127) of blumenol B
71 showed a total of thirteen carbon signals; four methyl, three methylenes, two
methines, three quaternary carbons and one carbonyl carbon which represented a C13
nor-isoprenoid skeleton.98 A downfield carbon signal was observed at δC 198.1 which
corresponded to the carbonyl group of C-3. The other two oxygenated carbons, C-6 and
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C-9, gave signals at δC 77.9 and δC 68.8. The stereochemistry of this compound was
confirmed through comparison with reported data98. There were two chiral centres in
this compound; C-6 and C-9. According to literature review,98 there are two
diastereomers; (6S, 9R) and (6R, 9R) found in plants. The difference of chemical shift at
C-7 could be used to distinguish between the diastereomers where 6S isomer (δH 1.84-
1.99, δC 34.8) had downfield signals of 1H and 13C-NMR for C-7 compared with 6R
isomer (δH 1.72-1.91, δC 33.5).98 Hence, blumenol B 71 has stereochemistry of 6S, 9R
by comparing with the reported 1H and 13C-NMR data. In addition, synthesis of
blumenol B 71 has been done by Weiss, Koreeda and Nakanishi (1973) to study its
stereochemistry.
Complete 1H and 13C-NMR assignments (Table 3.18) were established by
thorough analysis of COSY, HMBC and HSQC data. From the analysis of the
spectroscopic data obtained and comparison with the literature values,98,100,101 the
structure of blumenol B 71 was confirmed.
Figure 3.123: HMBC Correlation of Blumenol B 71
Chapter 3: Results and Discussion
197
Table 3.18: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Blumenol B 71 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(CDCl3)
Experimental
(CDCl3)
Reference*
(CDCl3)
1 - - 41.8 41.7
2β 2.48 (d, 18.3) 2.50 (d, 18.0) 50.1 50.0
2α 2.23 (d, 18.3) 2.25 (d, 18.0)
3 - - 198.1 198.0
4 5.84 (br s) 5.86 (dq, 1.4, 1.2) 126.1 126.1
5 - - 168.3 168.1
6 - - 77.9 77.8
7a 1.94-1.99 (m) 1.99 (m) 34.8 34.8
7b 1.79-1.89 (m) 1.84 (m)
8a 1.58-1.67 (m) 1.64 (m) 33.6 33.3
8b 1.47-1.56 (m) 1.53 (m)
9 3.75-3.81 (m) 3.79 (m) 68.8 68.8
10 1.22 (d, 6.0) 1.23 (d, 6.2) 24.3 24.2
11 1.08 (s) 1.09 (s) 23.8 23.8
12 1.04 (s) 1.06 (s) 24.0 23.9
13 2.04 (d, 0.9) 2.06 (d, 1.4) 21.8 21.7
*Literature value from Almeida et al. (2011).
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Figure 3.124: LCMS Spectrum of Blumenol B 71
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Figure 3.125: 1H NMR Spectrum of Blumenol B 71
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Figure 3.126: 13C NMR Spectrum of Blumenol B 71
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Figure 3.127: DEPT 135 NMR Spectrum of Blumenol B 71
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Figure 3.128: COSY Spectrum of Blumenol B 71
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3.2.18 Blumenol A 66
66
Blumenol A 66 [α] +146.6º (c 0.58, CHCl3) was afforded as a white
amorphous solid. The ESIMS (Figure 3.133) revealed a pseudomolecular ion peak
[M+H]+ at m/z 225.1665, corresponding to the molecular formula of C13H20O3 (calc.
225.1485). In UV spectrum, absorption maxima were observed at 237 nm.102 The IR
spectrum of showed an absorption peak at  3402, 1655 and 1124 cm−1which were due to
OH, C=O and C-O stretching vibrations respectively.102
This compound had similar structural skeleton with blumenol B 71. The only
difference was at C-7 and C-8. In 1H-NMR spectrum (Figure 3.134), a doublet and a
multiplet peaks were observed at δH 5.75 and δH 5.84 with coupling constant, J = 16.0
Hz which was attributed to H-7 and H-8, respectively indicating the presence of trans
double bond instead of two methylene protons in blumenol B 71. Two singlets were
observed at δH 1.05 and δH 0.98 which attributed to two methyl protons of H3-11 and
H3-12 respectively. The other two methyl protons resonated at δH 1.27 as doublet (3H,
d, J = 6.4 Hz, H3-10) and δH 1.87 (3H, d, J = 1.4 Hz, H3-13)
The 13C-NMR spectrum (Figure 3.135) of blumenol A 66 indicated a total of
thirteen carbon signals like blumenol B 71; four methyl, one methylenes, four methines,
three quaternary carbons and one carbonyl carbon which represented a C13 nor-
isoprenoid skeleton.103 The stereochemistry of this compound was assumed to be the
same as blumenol B 71 since both compounds were obtained from the same plant,
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therefore they are most probably biogenetically related. This hypothesis is supported by
the NMR data from the synthesized blumenol B by Yamano and Ito (2005).102
From the analysis of the spectroscopic data obtained (Table 3.19) and
comparison with the literature values,101,102,103,104,105,106,107 the structure of blumenol A
66 was confirmed.
Figure 3.132: HMBC Correlations of Blumenol A 66
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Table 3.19: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Blumenol A 66 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(CDCl3)
Experimental
(CDCl3)
Reference*
(CDCl3)
1 - - 41.3 41.1
2β 2.42 (d, 17.2) 2.44 (d, 17.5) 49.8 49.7
2α 2.21 (d, 17.2) 2.23 (d, 17.5)
3 - - 198.3 197.9
4 5.88 (br s) 5.90 (br s) 126.1 126.9
5 - - 163.2 162.7
6 - - 79.1 79.0
7 5.75 (d, 16.0) 5.78 (d, 16.0) 129.1 129.0
8 5.84 (m) 5.85 (dd, 16.0,
5.0)
135.8 135.7
9 4.38 (quintet,
6.4, 5.9)
4.40 (qd, 6.5,
5.0)
68.1 68.0
10 1.27 (d, 6.4) 1.29 (d, 6.5) 23.8 23.7
11 1.05 (s) 1.08 (s) 22.9 22.9
12 0.98 (s) 1.02 (s) 24.1 24.0
13 1.87 (d, 1.4) 1.90 (s) 19.1 18.9
*Literature value from Yamano and Ito (2005), Feng et al. (2010).
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Figure 3.133: LCMS Spectrum of Blumenol A 66
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Figure 3.134: 1H NMR Spectrum of Blumenol A 66
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Figure 3.135: 13C NMR Spectrum of Blumenol A 66
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Figure 3.136: HSQC Spectrum of Blumenol A 66
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Figure 3.137: HMBC Spectrum of Blumenol A 66
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3.2.19 β-sitosterol 73
73
β-sitosterol 73 [α] -55.6º (c 0.09, CHCl3) was obtained as a white amorphous
solid . The ESIMS (Figure 3.138) showed a pseudomolecular ion peak [M+H]+ at m/z
415.3561, corresponding to the molecular formula of C29H50O (calc. 415.3934). UV
spectrum showed absorption maxima at 203 nm.108 In IR spectrum, absorption peaks at
3425 and 2925 cm−1 were observed, indicating OH and sp3 C-H stretching vibration
respectively.108 The other peaks at 1465 and 1375 cm−1 were due to CH2 and CH3
bending.
In the 1H-NMR spectrum (Figure 3.139), a broad singlet at downfield region of
δH 5.34 which attributed to H-6 indicative of the presence of double bond functionality
between C-5 and C-6. Two singlet of methyl groups were observed at δH 0.67 and δH
0.99 which attributed to H3-18 and H3-19 respectively. Two methyl protons of H3-21
and H3-29 were observed as multiplets at δH 0.89-0.91 and δH 0.84-0.86 respectively
while the another two methyl protons; H3-26 and H3-27 were overlapped at δH 0.78-
0.83.
The 13C-NMR and DEPT spectra (Figure 3.140 and Figure 3.141) of β-sitosterol
73 indicated a total of twenty nine carbon signals; six methyl, eleven methylenes, nine
methines and three quaternary carbons which was in agreement with the molecular
Chapter 3: Results and Discussion
215
formula of β-sitosterol 73. The carbon signal at δC 71.9 indicated the presence of
oxymethine proton at C-3.
Complete 1H and 13C-NMR assignments (Table 3.20) were established by
thorough analysis of 2D-NMR data as well as reported data,37,108,109,110 thus the
compound was identified as β-sitosterol 73.
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Table 3.20: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of β-
sitosterol 73 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(CDCl3)
Experimental
(CDCl3)
Reference*
(CDCl3)
1a 1.81-1.85 (m) 37.3 37.3
1b 1.03-1.08 (m)
2a 1.94-2.02 (m) 32.0 31.6
2b 1.42-1.63 (m)
3 3.48-3.55 (m) 3.52 (m) 71.9 71.8
4 2.18-2.27 (m) 42.3 42.2
5 - - 140.8 140.8
6 5.34 (br s) 5.36 (br s) 121.8 121.7
7a 1.94-2.02 (m) 32.0 31.9
7b 1.42-1.63 (m)
8 1.81-1.85 (m) 31.7 31.9
9 0.89-0.91 (m) 50.2 51.2
10 - - 36.6 36.5
11 1.42-1.63 (m) 21.2 21.1
12a 1.94-2.02 (m) 39.8 39.8
12b 1.03-1.18 (m)
13 - - 42.4 42.3
14 0.99 (s) 56.8 56.8
15 1.03-1.18 (m) 24.8 24.3
16 1.81-1.85 (m) 28.3 28.3
17 1.03-1.18 (m) 56.1 56.0
18 0.67 (s) 0.68 (s) 11.9 11.9
19 0.98 (s) 1.01 (s) 19.5 19.4
20 1.24-1.38 (m) 36.2 36.2
21 0.89-0.91 (m) 0.92 (d, 6.4) 18.9 18.8
22a 2.30-2.35 (m) 33.8 33.9
22b 0.94-0.98 (m)
23 1.03-1.18 (m) 26.1 26.1
24 0.89-0.91 (m) 45.9 45.9
25 1.59-1.63 (m) 29.2 29.2
26 0.78-0.83 (m) 0.81 (d, 6.5) 19.9 19.8
27 0.78-0.83 (m) 0.83 (d, 6.5) 19.1 19.3
28 1.24-1.38 (m) 23.1 23.1
29 0.84-0.86 (m) 0.85 (t, 7.5) 12.1 12.2
*Literature values from Pateh et al. (2008).
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Figure 3.138: LCMS Spectrum of β-sitosterol 73
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Figure 3.140: 13C NMR Spectrum of β-sitosterol 73
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Figure 3.141: DEPT 135 Spectrum of β-sitosterol 73
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Figure 3.142: HSQC Spectrum of β-sitosterol 73
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3.2.20 Stigmast-4-en-3-one 57
57
Stigmast-4-en-3-one 57 [α] +75.0º (c 0.12, CHCl3) was yielded as a white
amorphous solid. The ESIMS (Figure 3.143) showed a pseudomolecular ion peak
[M+H]+ at m/z 413.2660, corresponding to the molecular formula of C29H48O (calc.
413.3778). UV spectrum showed absorption maxima at 241 nm.108 The IR spectrum of
showed absorption peak at 1675cm−1 indicated the presence of C=O group while
absorption peaks at 1468 and 1375 cm−1 were due to CH3 and CH2 bending
respectively.108
The 1H-NMR spectrum (Figure 3.144) of stigmast-4-en-3-one 57 closely
resemble that of β-sitosterol 73. The presence of a broad singlet at downfield region of
δH 5.73 were attributed to olefinic proton H-4. Two singlets of methyl groups were
observed at δH 0.71 and δH 1.18 which could be assigned to H3-18 and H3-19
respectively. Three methyl protons; H3-21, H3-26 and H3-27 were observed as doublet
at δH 0.92, δH 0.82 and δH 0.82 and δH 0.86 respectively while remaining methyl protons
(H3-29) resonated at δH 0.85-0.86 as multiplet.
The 13C-NMR spectrum (Figure 3.145) of stigmast-4-en-3-one 57 indicated a
total of twenty nine carbon signals; six methyl, eleven methylenes, nine methines and
three quaternary carbons. A downfield carbon signal was observed at δC 199.8 indicated
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the presence of carbonyl group at C-3. The other two downfield carbon signals of δC
123.7 and δC 171.8 were attributed to the olefinic carbons C-4 and C-5.
Based on the spectral data obtained (Table 3.21) and comparison with literature
data,37,108,110 the structure stigmast-4-en-3-one 57 was confirmed without doubt.
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Table 3.21: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
stigmast-4-en-3-one 57 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(CDCl3)
Experimental
(CDCl3)
Reference*
(CDCl3)
1a 2.00-2.05 (m) 35.6 35.7
1b 1.65-1.72 (m)
2a 2.32-2.37 (m) 34.0 33.9
2b 1.30-1.33 (m)
3 - - 199.8 198.9
4 5.73 (br s) 5.74 (d, 2.2) 123.7 123.6
5 - - 171.8 171.0
6 2.25-2.28 (m) 33.0 32.9
7a 1.82-1.89 (m) 32.1 32.1
7b 1.04-0.98 (m)
8 1.49-1.53 (m) 35.7 35.7
9 0.92-0.94 (m) 53.8 53.8
10 - - 38.6 38.6
11 1.42-1.44 (m) 21.0 21.0
12a 2.00-2.05 (m) 39.6 39.5
12b 1.15-1.10 (m)
13 - - 42.4 42.4
14 1.07-1.12 (m) 55.9 55.9
15a 1.62-1.63 (m) 24.2 24.1
15b 1.07-1.12 (m)
16a 1.82-1.88 (m) 28.2 28.1
16b 1.25-1.27 (m)
17 0.98-1.04 (m) 55.9 56.1
18 0.71 (s) 0.72 (s) 11.9 12.0
19 1.18 (s) 1.19 (s) 17.4 17.4
20 1.34-1.38 (m) 36.1 36.1
21 0.92 (d, 6.5) 0.93 (d, 6.6) 18.6 18.7
22 2.38-2.43 (m) 33.9 34.0
23 1.13-1.15 (m) 26.0 26.0
24 0.92-0.94 (m) 45.8 45.8
25 1.65-1.72 (m) 29.1 29.1
26 0.82 (d, 6.8) 0.84 (d, 6.8) 19.8 19.8
27 0.81 (d, 6.8) 0.82 (d, 6.8) 19.0 19.2
28 1.21-1.24 (m) 23.1 23.1
29 0.85-0.86 (m) 0.85 (d, 7.2) 12.0 11.1
*Literature values from Kolak et al. (2005).
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Figure 3.143: LCMS Spectrum of Stigmast-4-en-3-one 57
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Figure 3.144: 1H NMR Spectrum of stigmast-4-en-3-one 57
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Figure 3.145: 13C NMR Spectrum of stigmast-4-en-3-one 57
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n228 Figure 3.146: HSQC Spectrum of stigmast-4-en-3-one 57
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3.2.21 Vanillin 58
58
Vanillin 58 was isolated as a light brownish amorphous solid. The ESIMS
(Figure 3.148) displayed a pseudomolecular ion peak [M+H]+ at m/z 153.0555,
corresponding to the molecular formula of C8H8O3 (calc. 153.0546). In UV spectrum,
absorption bands at 308 and 277 nm were observed.111 The IR spectrum of showed
absorption peaks at 3365, 1661 and 1155 cm−1 which indicated OH, C=O and  C-O
stretching vibrations respectively.112,113
In 1H-NMR spectrum (Figure 3.149), H-5 resonated as a doublet at δH 7.03 (1H,
d, J = 8.7 Hz, H-5) while signals of H-2 and H-6 were seen to be overlapped between δH
7.40-7.42 (2H, m, overlapped, H-2, H-6). The presence of two singlets at δH 9.81 and δH
3.95 were attributed to the aldehyde and methoxyl groups respectively. A broad singlet
at δH 6.28 indicated the presence of a hydroxyl group. In addition, this signal did not
correlate to any carbon signal in the HSQC spectrum.
The 13C-NMR and DEPT spectra (Figure 3.150 and Figure 3.151) of vanillin 58
indicated a total of eight carbon signals; one methoxyl, three methines, three quaternary
carbons and one carbonyl carbon. Three quaternary carbons at δC 129.9, δC 147.2 and δC
151.8 was attributed to C-1, C-3 and C-4 respectively due to the connectivity of
aldehyde, methoxyl and hydroxyl group.
Complete 1H and 13C-NMR assignments (Table 3.22) were established by
thorough analysis of COSY, HMBC (Figure 3.148) and HSQC data. From the analysis
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of the spectroscopic data obtained and comparison with the literature,114,115 thus the
compound was identified as vanillin 58.
Figure 3.147: COSY and HMBC Correlations of Vanillin 58
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Table 3.22: 1H-NMR (400 MHz) and 13C-NMR (100 MHz) Spectral Data of
Vanillin 58 in CDCl3.
Position 1H 13C
δH (multiplicity, J in Hz) δC
Experimental
(CDCl3)
Reference*
(CDCl3)
Experimental
(CDCl3)
Reference*
(CDCl3)
1 - - 129.9 129.5
2 7.40-7.42 (m,
overlapped)
7.42 (d, 2.0) 108.8 109.4
3 - - 147.2 147.5
4 - - 151.8 152.3
5 7.03 (d, 8.7) 7.04 (d, 8.0) 114.5 114.8
6 7.40-7.42 (m,
overlapped)
7.43 (dd, 8.0, 2.0) 127.7 127.4
CHO 9.81 (s) 9.83 (s) 191.0 191.3
OMe 3.95 (s) 3.96 (s) 56.2 56.0
OH 6.28 (br s) 6.38 (s) - -
*Literature value from Xuan et al. (2005) and Pelter et al. (1976).
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Figure 3.148: LCMS Spectrum of Vanillin 58
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Figure 3.149: 1H NMR Spectrum of Vanillin 58
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Figure 3.150: 13C NMR Spectrum of Vanillin 58
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n235 Figure 3.151: DEPT 135 Spectrum of Vanillin 58
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Figure 3.152: COSY Spectrum of Vanillin 58
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Figure 3.153: HSQC Spectrum of Vanillin 58
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Figure 3.154: HMBC Spectrum of Vanillin 58
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4.1 General
Corynanthe type of indole alkaloids are known to possess anti-proliferative,
cytotoxic and anti-cholinesterase activities. Angustine 42 and 10-hydroxyangustine 6
which isolated from Nauclea orientalis exhibited good anti-proliferative activity against
both T-24 and EGF dependent MK cells.15 Besides, Sichaem et al. (2012) reported that
naucleficine 64 and naucleidinal showed significant cytotoxic activity against both
HeLa and KB cell lines.116 In addition, angustine 42 also exhibited good anti-
cholinesterase activity where it has been shown to be potent inhibitor toward BChE.117
4.2 Cytotoxic activity
Prostate cancer is the most frequently diagnosed cancer among men in the
developed world. An estimated 238,590 new cases will be diagnosed and 29,720 deaths
will result from prostate cancer in the United States in 2013 (Cancer Facts and Figures
2013, American Cancer Society, 2013). Although the mechanisms that drive prostate
cancer have not been completely understood, age, race, and family history of the
prostate cancer patients have been shown to be potential factors closely associated with
this terminal disease.118
4.2.1 Cell culture
Human prostate normal cell line (RWPE-1) and human prostate cancer cell lines;
LNCaP and PC-3, were purchased from the American Type Culture Collection (ATCC,
Manassas, Virginia, USA). LNCaP and PC-3 cells were grown in Roswell Park
Memorial Institute medium (RPMI) supplemented with 10% heat-inactivated fetal
bovine serum (FBS, Sigma-Aldrich, St. Louis, MO), 1% penicillin and streptomycin.
RWPE-1 cells were maintained in Keratinocyte Serum Free Medium (K-SFM, ATCC)
supplemented with bovine pituitary extract (BPE) and human recombinant epidermal
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growth factor (EGF). Mediums were supplemented with 10% heat-inactivated fetal calf
serum (Sigma.), 100 U/mL penicillin and 100 mg/ml streptomycin (Flowlab, Sydney,
Australia). All cells were maintained in a humidified atmosphere of 5% CO2 in air at
37°C incubator.
4.2.2 Cell proliferation assay
The anti-proliferative activity of the compounds was evaluated by performing
MTT assays as previously described with minor modifications.119 Briefly, cells were
seeded 24 hours prior to treatment in a 96-well plate at 5 × 104 cells/well in order to
obtain 70% to 80% confluent cultures. The compounds were dissolved in DMSO
(Sigma Chemical Co., St. Louis, Missouri, USA) followed by a 2× serial dilution for 10
points ranged from 0.825 μM to 100 μM. The 96-well plate was incubated for 24 hours
at 37°C in a humidified atmosphere with 5% CO2. At the end of incubation, 50 μl of
MTT solution (2 mg/mL; Sigma) was added to each well. The plate was then incubated
for 4 hours. All medium was removed and the purple formazan crystal formed at the
bottom of the wells was dissolved with 200 μl DMSO for 20 minutes. The absorbance at
570 nm was read on a spectrophotometric plate reader (Hidex). The proportion of
surviving cells was calculated as:
(OD of drug-treated sample – OD of blank)/(OD of control – OD of blank) × 100%.
Dose-response curves were constructed to obtain the IC50 values. Experimental data
were derived from 3 independent experiments. The selectivity index was obtained by
mean  IC50 RWPE-1 / mean IC50 of LNCaP or PC-3.
4.2.3 Results and discussion
The cytotoxic effect of dichloromethane crude, subditine 72, angustoline 43,
angustidine 44, angustine 42 and nauclefine 63 were evaluated on human prostate
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cancer cells LNCaP and PC-3 by MTT assays. IC50 values (dose required to inhibit the
proliferative response by 50%) for each compound was shown in Table 4.1. Subditine
72 showed great inhibitory effect towards LNCaP cells at IC50 12.24 ± 0.19 μM while
IC50 for angustoline 43, angustidine 44, angustine 42 and nauclefine 63 were 58.09 ±
0.05 μM, 140.27 ± 0.10 μM, 149.16 ± 0.09 μM and 86.35 ± 0.09 μM respectively.
Similar findings were obtained on PC-3 cells, where subditine 72 exhibited the highest
activity (IC50 = 13.97 ± 0.32 μM) compared to the other compounds. These findings
indicate that subditine 72 is the most potent cytotoxic compound among the five tested.
Subsequently, the cytotoxicity effect of subditine 72 was tested on on RWPE-1
(human normal prostate epithelial cells). MTT assay showed a higher IC50 value at
30.48 ± 0.08 μM, indicating that subditine 72 is 2.5 and 2.2 folds more potent against
LNCaP and PC-3 (selectivity index (SI): [LNCaP/PC-3] = 2.49/2.18) prostate cancer
cells than the normal prostate cells; RWPE-1. In contrast, standard anti-cancer drug
paclitaxel showed less selectivity (SI: [LNCaP/PC-3] = 1.24/1.19) by exhibiting IC50
values of 1.27 ± 0.04 μM, 1.33 ± 0.02 μM and 1.58 ± 0.06 μM against LNCaP, PC-3
and RWPE-1 respectively.
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Table 4.1: Subditine 72, angustoline 43, angustidine 44, angustine 42 and nauclefine 63
and standard drug paclitaxel screening on LNCaP and PC-3 human prostate cancer and
RWPE human normal prostate epithelial cell-lines using MTT assays. 24 hours post
treatment, MTT salt was dissolved with DMSO and the absorbance was measured with
Hidex microplate reader at 570 nm.
Compounds IC50 values at 24 hours (μM)
LNCaP PC-3 RWPE-1
Subditine 72 12.24 ± 0.19 13.97 ± 0.32 30.48 ± 0.08
Angustoline 43 58.09 ± 0.05 67.31 ± 0.87 65.94 ± 0.04
Angustidine 44 140.27 ± 0.10 84.91 ± 1.48 36.07 ± 0.05
Angustine 42 149.16 ± 0.09 121.59 ± 3.73 98.39 ± 0.10
Nauclefine 63 86.35 ± 0.09 92.07 ± 1.28 72.85 ± 0.06
Paclitaxel (Reference drug) 1.27 ± 0.04 1.33 ± 0.02 1.58 ± 0.06
4.3 Cholinesterase inhibition assay
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by
neuronal loss in the brain region involved in cognitive functions.120 Based on the
cholinergic hypothesis, the neuronal loss eventually results in low levels of
acetylcholine (ACh) neurotransmitter in the affected region of the brain leading to
impaired cholinergic neurotransmission and clinical symptoms of AD. Cholinesterases,
namely the acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are the
enzymes that catalyze the hydrolysis of acetylcholine, an essential process in
cholinergic neurotransmission.121 Therefore the enhancement of ACh level using
cholinesterase inhibitors (ChEIs) is one of the approaches to treat AD. AChE inhibitors
such as donepezil, rivastigmine and galanthamine are currently still the best available
pharmacotherapy for AD patients, producing symptomatic improvements in mild to
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moderate AD patients.122 The recent development of inhibitors includes drugs with high
selectivity for BChE, which also showed enhancement of ACh levels in rats brain,
without triggering severe peripheral or central cholinergic adverse effects.123,124
Despite the long history of AD, there are very few ChEIs available for the
treatment of AD. Natural products especially the plant-based alkaloids, have been
viewed as promising drug candidates and had contributed significantly in drug
discovery and development of ChEIs for AD. For example, ChEIs inhibitors, including
those used clinically such as galanthamine, huperzine A and physostigmine are
alkaloids isolated from plants; Galanthus spp., Huperzia serrata and Physostigma
venenosum, respectively.125
4.3.1 Chemicals and enzymes
Acetylcholinesterase from electric eel, 5,5′-dithiobis(2-nitrobenzoic acid),
acetylthiocholine iodide (ATCI), butyrylcholine esterase from equine serum, S-
butyrylthiocholine chloride and galanthamine hydrobromide were purchased from
Sigma (St Louis, MO). Sodium dihydrogen phosphate anhydrous was purchased from
R&M Chemicals (Essex, UK) while disodium hydrogen phosphate anhydrous was
purchased from Merck (Darmstadt, Germany). All the other solvents and reagents used
were of analytical grade.
4.3.2 In vitro cholinesterase inhibitory assay
Cholinesterase inhibitory activity of the extracts and isolated compounds was
evaluated following Ellman’s microplate assay as described by Ahmed and Gilani
(2009).126 Briefly, for AChE inhibitory assay, 140 μL of 0.1 M sodium phosphate buffer
(pH 8) was first added to each well of a 96-well microplate followed by 20 μL of the
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test sample; naucletine 61, angustidine 44, nauclefine 63, angustine 42, naucline 56,
angustoline 43, harmane 67, 3,14-dihydroangustoline 68, strictosamide 70 and
pumiloside 69 (in 10 % methanol) and 20 μL of 0.09 unit/ml AChE. After 15 minutes of
pre-incubation at 25 °C, 10 μL of 10 mM 5,5′-dithiobis(2-nitrobenzoic acid) was added
into each well followed by 10 μL of 14 mM acetylthiocholine iodide (ATCI). The
absorbance of the colored end-product was measured at 412 nm at designated intervals
for 30 minutes after the initiation of enzymatic reaction by Tecan Infinite 200
ProMicroplate Spectrometer (Switzerland). For BChE inhibitory assay, the same
procedure was followed except that the enzyme and substrate used were BChE from the
equine serum and S-butyrylthiocholine chloride respectively. Galanthamine was used as
the reference standard. Each sample test was conducted in triplicate. Absorbance of the
test sample was corrected by subtracting the absorbance of its respective blank. A set of
five concentrations was used to estimate the 50 % inhibitory concentration (IC50) for the
active compounds.
4.3.3 Molecular docking
Molecular docking of angustidine 44 and nauclefine 63 were performed using
Autodock 3.0.5 along with AutoDockTools (ADT).127 The compounds were built by
sing Hyperchem 8 and energy minimization was performed with a convergence
criterion of 0.05 kcal/(molA). Crystal structures of AChE from Torpedo californica in
complex with galanthamine and BChE from Homo sapiens were obtained from Protein
Data Bank with PDB ID: 1W6R128 and PDB ID: 2WIJ129, respectively. Both proteins
were edited using ADT to remove all water molecules and hydrogen atoms were added.
Non-polar hydrogens and lone pairs were then merged and each atom was assigned with
Gasteiger partial charges. A grid box of 60 × 60 × 60 points, with a spacing of 0.375 Ǻ
was positioned at the center of active site gorge. One hundred independent dockings
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were carried out for each docking experiment. The lowest docked energy of each
conformation in the most populated cluster was selected. Analysis and visualization of
the docking results were done using VMD130 and Acceryls Discovery Studio 2.5
(Accelrys Inc., San Diego, CA, USA).
4.3.4 BChE kinetic study
Kinetic studies of BChE inhibition was determined by constructing Lineweaver-
Burk (LB) plots; reciprocal plots of 1/V versus 1/[S] at different concentrations of
substrate S-butyrylthiocholine chloride (1.75 mM to 14.0 mM) in the absence and
presence of two different concentrations of inhibitors (33.2 and 66.4 μM). The Ki value
was estimated from the replots of the slope of the individual LB plots versus the
inhibitor concentrations.
4.3.5 Results and Discussion
Results and discussion for anti-cholinesterase activity were divided into three
parts; cholinesterase inhibition studies, molecular docking of angustidine 44 and
nauclefine 63 and BChE kinetic study of angustidine 44.
4.3.5.1 Cholinesterase inhibition studies
The CH2Cl2 (bark) and MeOH (leaves) extract from Nauclea officinalis showed
moderate BChE inhibition; IC50 values of 97.33 ± 5.07 μg/mL and 132 ± 12.7 μg/mL
respectively. Therefore, the phytochemicals from both extracts were isolated and then
tested for both BChE and AChE. The determination of cholinesterase inhibitory activity
on AChE and BChE were evaluated according to colorimetric Ellman’s method131.
Table 4.2 summarizes the cholinesterase inhibitory activity of the extracts, while Table
4.3 summarizes the IC50 and selectivity indices of the isolated alkaloids and the standard,
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galanthamine. Naucletine 61, angustidine 44, nauclefine 63, angustine 42, naucline 56
and angustoline 43 were obtained from bark of CH2Cl2 extract while harmane 67 and
3,14-dihydroangustoline 68 were isolated from leaves of  CH2Cl2 extract. Strictosamide
70 and pumiloside 69 were obtained from the leaves of MeOH extract. All the indole
alkaloids except pumiloside 69 displayed strong to weak BChE inhibitory effect with
the IC50 values in the range of 1.02-168.55 μM while three compounds (angustidine 44,
angustoline 43 and pumiloside 69) showed moderate to weak AChE inhibition with IC50
values in the range of 21.71-261.89 μM. It is interesting to note that five compounds;
harmane 67, angustidine 44, angustine 42, nauclefine 63 and angustoline 43 were more
potent BChE inhibitors than galanthamine. Angustidine 44 was found to be the most
potent inhibitor of both AChE and BChE among the isolated alkaloids with higher
selectivity toward BChE (selectivity index = 21.09).
Table 4.2: Cholinesterase inhibitory activities of N. officinalis extracts
Extracts AChE BChE
% inhibition at
200 μg/mL
IC50 (μg/mL) % inhibition at
200 μg/mL
IC50 (μg/mL)
CH2Cl2 (Bark) 0.55 ND 82.51 97.33 ± 5.07
MeOH (Bark) 28.55 ND NA ND
CH2Cl2 (Leaves) NA ND 5.44 ND
MeOH (Leaves) 11.67 ND 54.13 132 ± 12.7
ND = not determined
NA= no activity
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Table 4.3: Cholinesterase inhibitory activities of alkaloids from N. officinalis
Compounds % inhibition at 100 μg/ml IC50 Selectivity
AChE BChE AChE BChE AChEa BChEb
μg/mL μM μg/mL μM
Naucletine 61 34.19 ± 7.06 62.02 ± 1.37 ND ND 20.78 ± 3.06 63.14 - -
Angustidine 44 82.62 ± 2.35 95.88 ± 0.50 6.54 ± 0.37 21.72 0.31 ± 0.07 1.03 0.05 21.09
Nauclefine 63 34.61 ± 4.84 75.31 ± 16.61 ND ND 2.21 ± 0.03 7.70 - -
Angustine 42 40.19 ± 0.65 83.97 ± 1.35 ND ND 1.56 ± 0.05 4.98 - -
Naucline 56 35.27 ± 4.74 82.47 ± 1.10 ND ND 12.17 ± 2.23 38.25 - -
Angustoline 43 77.53 ± 4.40 82.5 ± 0.67 86.72 ± 5.41 261.89 8.31 ± 1.25 25.10 0.10 10.43
Harmane 67 58.42 ± 4.98 96.72 ± 1.53 54.75 ± 0.88 300.68 2.4 ± 0.13 13.18 0.04 22.81
3,14-dihydroangustoline 68 38.55 ± 5.94 72.82 ± 1.60 ND ND 16.58 ± 1.35 49.77 - -
Strictosamide 70 34.76 ± 3.27 56.01 ± 0.93 ND ND 83.97 ± 0.61 168.54 - -
Pumiloside 69 54.96 ± 12.15 17.38 ± 5.47 60.62 ± 4.98 118.36 ND ND - -
Galanthamine (standard) - - 0.27 ± 0.07 0.94 8.12 ± 0.61 28.29 30.10 0.03
Data presented as Mean ± SD (n=3)
ND = not determined
a Selectivity for AChE is defined as IC50(BChE)/IC50(AChE)
bSelectivity for BChE is defined as IC50(AChE)/IC50(BChE)
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There are few studies reporting on the cholinesterase inhibitory activity of
alkaloids, for instance Torres et al. (2012) reported similar results for harmane 67 with
IC50 values of 330 and 90 μM against AChE and BChE respectively.132 In contrast,
Zhao et al. (2013) reported that harmane 67 had better AChE inhibitory activity than on
BChE, with IC50 values of 7.11 and 76.91 μM respectively.133 The difference may be
due to the fact that Torres et al. (2012) used the same concentration of both AChE and
BChE while Zhao et al. (2013) used a higher concentration for AChE than BChE (0.087
unit/mL for AChE and 0.035 unit/mL for BChE). In the present study, the author has
used the same concentration for both enzymes (0.09 unit/mL) and the results obtained
agreed with the finding of Torres et al. (2012).
Passos et al. (2013) reported the inhibitory activity of angustine 42 and
strictosamide 70.117 The former showed good inhibitory activity against BChE with IC50
of 3.47 μM, while the latter showed a weak activity with IC50 of more than 100 μM.
Both compounds showed poor AChE inhibitory activity with IC50 of more than 100 μM.
On the selectivity, it is interesting to note that all the alkaloids except pumiloside
69 were selective inhibitor of BChE, unlike galanthamine that was an AChE selective
inhibiting alkaloid. Despite being 23 times less potent than galanthamine against AChE,
on a molar basis comparison, angustidine 44 was 28 times more potent inhibitor of
BChE than galanthamine. AChE is of prime importance as compared to BChE, but both
enzymes complements one another for their role in cholinergic neurotransmission. From
some recent studies, it was postulated that progressive decline in activity of AChE in
certain brain regions during the progression of AD, is replaced by progressive increase
in BChE activity, which may act as a compensatory mechanism for ACh hydrolysis134.
Owing to the growing importance of BChE, an agent that inhibits BChE would be
beneficial especially during the later stages of AD. In addition, a BChE selective
inhibitor would be expected to cause less peripheral cholinergic adverse effects.
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In a review on cholinesterase from medicinal plants, alkaloids in general were
reported to have IC50 values in the range of 6x10-4 μM up to more than 2000 μM. A
closer look reveals that indole and lycopodane-type alkaloids are weak inhibitor of
AChE, while isoquinoline, quinazoline, quinolizidine, triterpenoidal and steroidal
alkaloids are good to moderate AChE inhibitors. On the other hand, some triterpenoidal
alkaloid, in particular buxakashmiramine (IC50 0.74 μM) showed good to potent BChE
inhibitory activity. Likewise, isoquinoline and steroidal alkaloids are good to moderate
BChE inhibitors, but lycopodane-type alkaloids lack BChE inhibitory activity135. The
indole alkaloids isolated in the present study showed comparable inhibitory activity
with previously reported alkaloids, however these alkaloids were more BChE selective.
This is the first report on the BChE inhibition potential of of naucletine 61, nauclefine
63, naucline 56, angustoline 43, 3,14-dihydroangustoline 68 and angustidine 44, which
exhibited the most potent activity.
4.3.5.2 Molecular docking of angustidine 44 and nauclefine 63
The BChE inhibition studies have shown that angustidine 44 revealed the most
potent activity followed by angustine 42 and nauclefine 63. In order to understand the
binding mechanisms of these compounds with cholinesterase enzyme, molecular
docking study was performed on both angustidine 44 and nauclefine 63. The molecular
docking of angustine 42 was not performed as it has been reported before117. Passos et
al. (2013) reported that the binding of angustine 42 with hBChE involved hydrophobic
interaction of Trp 82, Trp 231, Leu 286 and Phe 329 with its aromatic moieties.117 The
interaction sites, residue involved and bonding types as well as the ligand interacting
moiety are summarized in Table 4.4. The findings indicate that angustidine 44 docked
deep into the bottom gorge of hBChE, forming hydrogen bonds with Ser 198 and His
438 (Figure 4.1). The hydrogen bonds formed with the amino acid residues at the
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catalytic site could be responsible for the potency of angustidine 44 as BChE inhibitor.
On the other hand, angustidine 37 was well accommodated, forming π-π stacking
interaction with Trp84 at choline binding site, which anchored this compound to the
TcAChE active site gorge (Figure 4.2). Meanwhile, nauclefine 63 formed hydrogen
bond with Gly 116 at the oxyanionic hole and π-π interactions were observed between
His 438 of hBChE and aromatic ring of nauclefine 63 (Figure 4.3). Since the active site
of BChE has many of the channel-lining aromatic residues replaced by residues with
aliphatic side chains, it is able to accomodate bulkier compounds compared to AChE.
Due to space availability, both angustidine 44 and nauclefine 63 were able to
accomodate and docked completely into the base of the active site and held in place by
the hydrogen bond. In contrast, Passos et al. (2013) reported that angustine 42 was
mainly stabilized by hydrophobic interactions involving its aromatic moieties with Trp
82, Trp 231, Leu 286 and Phe 329 residues of BChE.117
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Table 4.4: Binding interaction data for bioactive alkaloids from N. officinalis docked into active site gorge of AChE and BChE
Compound Enzyme Binding
Energy
(kcal)
Interacting site Residue Type of
Interaction
Distance
(Å)
Ligand
Interacting
Angustidine 44 TcAChE -11.53 CBS* Trp 84 Hydrophobic 3.47 Aromatic ring
hBChE -10.14 CS** Ser 198
His 438
Hydrogen 1.83
2.76
C-19
C-19
Nauclefine 63 hBChE -10.15 CS** His 438 Hydrophobic 3.44
4.09
5.21
Aromatic ring
Aromatic ring
Aromatic ring
OH*** Gly 116 Hydrogen 2.25 C-18
*Choline binding site
**Catalytic site
*** Oxyanion hole
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Figure 4.1: Binding interaction of angustidine 44 with active site residue hBChE
Figure 4.2: Binding interaction of angustidine 44 with active site residues of TcAChE
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Figure 4.3: Binding interaction of nauclefine 63 with active site residue hBChE
4.3.5.3 BChE kinetic study of angustidine 44
The mode of inhibition for angustidine 44 on BChE was further investigated to
determine their inhibition constant, Ki values. The catalytic rates of BChE were
measured in the absence of inhibitor and presence of two concentrations of inhibitor;
angustidine 44 (33.2 and 66.4 μM) by constructing Lineweaver-Burk (LB) plot over a
range of substrate concentrations (1.75 to 14.0 mM) (Figure 4.4). Graphical analysis of
LB plot constructed for BChE suggested mixed type inhibition. In addition, Ki value of
6.12 μM was obtained by plotting the slope of the individual LB plots versus the
inhibitor concentrations (Figure 4.5).
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Figure 4.4: Lineweaver-Bulk (LB) plot of BChE activity over a range of substrate
concentration (1.75 to 14.0 μM) for angustidine 44.
Figure 4.5: The Ki value (6.12 μΜ) for BChE inhibition by angustidine 44 was obtained
by plotting the slopes of LB plots versus inhibitor concentrations.
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CONCLUSION
Phytochemical study on bark and leaves of two species of Rubiaceae; Nauclea
officinalis (KL 5655 and KL 4745) and Nauclea subdita (KL 5254) were carried out.
Nauclea officinalis were collected from Hutan Simpan Madek, Keluang, Johor and
Hutan Simpan Mersing Johor while Nauclea subdita were collected from Hutan Simpan
Bukit Kinta, Chemor, Perak.
The chemical investigation of this three plants afforded twenty one compounds
including two new indole alkaloids; naucline 56 and subditine 72 along with eleven
known indole alkaloids; nauclefine 63, naucletine 61, angustine 42, angustoline 43,
3,14-dihydroangustoline 68, angustidine 42, strictosamide 70, naucleficine 64,
naucleactonin C 65, harmane 67 and 1,2,3,4-tetrahydro-1-oxo-β-carboline 60, one
quinoline alkaloid glycoside; pumiloside 69, two triterpenes; stigmast-4-en-3-one 57
and β-sitosterol 73, two amides; benzamide 62 and cinnamide 59, two C13 nor-
isoprenoids; blumenol A 66 and blumenol B 71 as well as one benzaldehyde; vanillin
58. The structure of all these compounds were elucidated with extensive spectroscopic
methods namely 1D-NMR (1H, 13C, DEPT), 2D-NMR (COSY, HSQC, HMBC,
NOESY) and comparison with reported data.
Subditine 72 showed potent inhibitory effect towards LNCaP cells at IC50 12.24
± 0.19 μM and PC-3 cells at IC50 = 13.97 ± 0.32 μM comparable to standard drug;
palitaxel (1.27 ± 0.04 and 1.33 ± 0.22 for LNCaP and PC-3 respectively). Angustoline
43, angustidine 44, angustine 42 and nauclefine 63 exhibited moderate to weak
inhibitory effect toward both prostate cancer cell lines. Besides, MTT assay showed that
subditine 72 exhibited a higher IC50 value at 30.48 ± 0.08 μM on RWPE-1 (human
normal prostate epithelial cells), indicating that subditine 72 is 2.5 and 2.2 folds more
potent against LNCaP and PC-3 (selectivity index (SI): [LNCaP/PC-3] = 2.49/2.18)
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prostate cancer cells than the normal prostate cells; RWPE-1. On the other hand,
standard drug paclitaxel had less selectivity (SI: [LNCaP/PC-3] = 1.24/1.19) with IC50
values of 1.27 ± 0.04 μM, 1.33 ± 0.02 μM and 1.58 ± 0.06 μM against LNCaP, PC-3
and RWPE-1 respectively.
For cholinesterase inhibitory studies, all the indole alkaloids except pumiloside
69 displayed strong to weak BChE inhibitory effect with the IC50 values in the range of
1.02 -168.55 μM while angustidine 44, angustoline 43 and pumiloside 69 showed
moderate to weak AChE inhibition with the IC50 values in the range of 21.71-261.89
μM. Angustidine 44 was the most active inhibitor of both AChE and BChE with IC50
values of 21.72 μM and 1.03 μM, respectively. All the alkaloids except pumiloside 69
were BChE selective inhibitors. Interestingly, five compounds; angustidine 44,
nauclefine 63, angustine 42, angustoline 43 and harmane 67 exhibited more potent
inhibitory toward BChE than galanthamine. Angustidine 44, nauclefine 63, angustine 42,
angustoline 43 and harmane 67 acts at different sites of the cholinesterases, interacting
with the choline binding site of AChE and catalytic site of BChE. Angustidine 44
docked deep into the bottom gorge of hBChE, forming hydrogen bonding with Ser 198
and His 438. The nature of protein-ligand interactions is mainly hydrophobic with
AChE and via hydrogen bonding with BChE. Kinetic study shown that angustidine 44
exhibited mixed type inhibition with estimated Ki value of 6.12 μM. Overall, the nine
indole alkaloids; naucletine 61, angustidine 44, nauclefine 63, angustine 42, naucline 56,
angustoline 43, harmane 67, 3,14-dihydroangustoline 68, strictosamide 70 had potent to
moderate BChE inhibitory activity and could serve as potential lead compounds for
further drug research study of AD agents.
In conclusion, it may be deduced that both plants; Nauclea officinalis and
Nauclea subdita are rich source of indole alkaloids with interesting activity and skeletal
features. These compounds could be investigated further for various type of maladies
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such as diabetes and inflammation. More extensive studies may also be performed on
the active compounds such as subditine 72 and angustidine 44 in moves to develop
therapeutic agents for cancer and Alzheimer’s disease, respectively.
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6.1 Plant Material
The plant materials were collected and identified by the phytochemical group of
the Department of Chemistry, Faculty of Science, University of Malaya. They were
deposited at the Herbarium of the Department of Chemistry, University of Malaya,
Kuala Lumpur, Malaysia. The plant species and their respective localities are shown in
Table 6.1 below.
Table 6.1: Plant species and locality
Voucher
specimen
Species Part of plant Locality and date of
collection
KL 5655 N. officinalis Bark and
leaves
Hutan Simpan Madek,
Keluang, Johor, Malaysia.
22nd April 2009
KL 4745 N. officinalis Bark and
leaves
Hutan Simpan Mersing,
Johor, Malaysia.
22nd October 1997
KL 5254 N. subdita Bark and
leaves
Hutan Simpan Bukit Kinta,
Chemor, Perak, Malaysia.
20nd June 2006
6.2 Solvent
All solvents were of AR grade. Those used for bulk extraction were distilled
prior to use. The solvents used were hexane, dichloromethane, methanol, ammonia
solution, hydrochloric acid.
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6.3 Instrumentation
The 1D- and 2D-NMR spectra were recorded either in deuterated chloroform
(CDCl3), deuterated methanol (CD3OD), deuterated pyridine (C5D5N) and deuterated
N,N-Dimethyl formamide (DMF-d7) using the JEOL LA 400 FT NMR, JEOL ECA 400
FT NMR, BRUKER Advance III 400 NMR and BRUKER Advance III 600 NMR
spectrometers.
The ESIMS and LCMS-IT-TOF spectra were obtained from Agilent
Technologies 6530 Accurate-Mass Q-TOF LC/MS and UPLC Shimadzu liquid
chromatography with an SPD-M20A diod array detector coupled to an IT-TOF mass
spectrometer respectively.
The ultraviolet absorption spectra were recorded using a Shimadzu UV-250
Ultraviolet-Visible Spectrophotometer. Solvent used was spectroscopic grade methanol
(CH3OH).
IR spectra were recorded on a Perkin Elmer Spectrum FTIR Spectrometer RX1
with spectroscopic grade chloroform as the solvent.
A Jasco P-1020 polarimeter was used to record the optical rotation.
6.4 Chromatography
Purification processes were performed using various chromatography
techniques such as column chromatoghraphy and preparative thin layer chromatography.
6.4.1 Thin Layer Chromatography (TLC)
Aluminum supported silica gel 60 F254 (Merck) were used for Thin Layer
Chromatography (TLC). The crude extract, fractions from column chromatography and
isolated compounds were examined using TLC. By using a piece of fine glass capillary
tube, the TLC plates were spotted and placed in chromatographic tanks saturated with
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the developing solvent system. The spots developed on the TLC plates were visualized
under a UV Lamp Model UVGL-58 (254 and 365 nm), followed by spraying with
Dragendorff”s reagent.
6.4.2 Column Chromatography (CC)
Silica gel 60, 70 - 230 mesh ASTM (0.063 - 0.200 mm) and 230 - 400 mesh
ASTM (0.040 - 0.063 mm) (Merck) were used for column chromatography. A slurry of
silica gel 60 was prepared and poured into a glass column with a particular dimension.
The crude extract was dissolved in minimum amount of solvent and applied on to the
top of the column. The extract was loaded to column and eluted from the column with
gradient solvent system.
6.4.3 Preparative Thin Layer Chromatography (PTLC)
PTLC silica gel 60 F254 glass plate (20 x 20 cm) were used for isolation of
compounds that cannot be achieved by conventional column chromatography. Bands on
the PTLC were visualized using a UV Lamp Model UVGL-58.
6.5 Reagents
Reagents used for detection of alkaloid contents were Mayer’s reagent and
Dragendorff’s reagent.
6.5.1 Mayer’s Reagent (potassium mercuric iodide)
For Mayer’s reagent, 1.4g of mercuric iodide in 60 mL of distilled water was
mixed with 5.0 g of potassium iodide in 10 mL of distilled water. The mixture was then
made up to a 100 mL solution. A positive test result was indicated by the formation of
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white precipitate when the aqueous layer (acidified) is treated with 2 to 3 drops of
Mayer’s reagent.
6.5.2 Dragendorff’s Reagent (potassium bismuth iodide)
Bismuth (III) nitrate (0.85 g) in a mixture of glacial acetic acid (10 mL) and
distilled water (40 mL) as solution A. Potassium iodide (8.0 g) in distilled water (200
mL) as solution B. Stock solution was prepared by mixing solution A and solution B in
equal volumes. The stock solution (20 mL) was then diluted in a mixture of acetic acid
(20 mL) and distilled water (60 mL) to prepare the spray reagent. A positive test result
was indicated by the formation of on orange spot.
6.6 Extraction of the bark
First, the respective dried, grounded samples (N. officinalis from Madek, N.
officinalis from Mersing and N. subdita) were defatted with hexane (17 L) for three
days at room temperature (Scheme 6.1). Then, the hexane extract was filtered and dried
on the rotary evaporator. The residues were dried and then later moistened with 28% of
ammonia solution (NH3) and left for 2 hours. They were then re-extracted with
dichloromethane (CH2Cl2) (17 L) for three days at room temperature and the CH2Cl2
extract was dried using a rotarary evaporator to obtain the CH2Cl2 crude. Finally, the
residues were soaked with methanol (MeOH) (17 L) at room temperature for three day
period and the MeOH crude was dried using a rotarary evaporator. The hexane crude
was obtained as a yellowish residue while the CH2Cl2 and MeOH crudes were each
obtained in the form of a dark brown residue.
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- extraction with hexane
- moistened with 28% NH3
- extraction with CH2Cl2
-extraction with MeOH
Scheme 6.1: Extraction of bark.
6.7 Extraction of leaves
Extraction procedures for leaves were almost the same as bark but with
additional acid-base extraction for CH2Cl2 extract (Scheme 6.2). First, the dried plant
materials were soaked with hexane (17 L) for three days at room temperature. Then, the
hexane crude was obtained by filtration followed by the drying using rotarary
evaporator. The residues were dried at room temperature and then moistened with 28%
of NH3 and left for 2 hours. They were then re-extracted with CH2Cl2 (17 L) for three
days at room temperature to obtained CH2Cl2 extract.
Next, the CH2Cl2 extract was concentrated under reduced pressure to a volume
of approximately 500 mL. The alkaloid content in the extract was tested using TLC and
spraying the developed TLC plate with Dragendroff’s reagent. The dichloromethane
extract was then extracted with 5% of hydrochloric acid and monitered with the
Plant materials
Residue Hexane extract
CH2Cl2 crude Residue
MeOH crude Residue
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Mayer’s reagent test. The hydrochloric acid solution obtained was basified with NH3
solution to a pH of 11 followed by extraction with CH2Cl2 again. The CH2Cl2 extract
then was washed with distilled water and dried with sodium sulphate anhydrous and
finally concentrated under reduced pressure to give the CH2Cl2 crude.
The residues were soaked again with MeOH (17 L) for three day period at room
temperature to obtain MeOH crude. The hexane crude, CH2Cl2 crude and MeOH crude
were each obtained in the form of a dark green residue.
The same procedures were applied on all the leaves for the three plants. The
amount of the plant materials used for extraction and the yield for all the crudes are
listed in Table 6.2.
- add 50 mL CH2Cl2
- add 5% HCl (until Mayer’s test negative)
- partition
- add NH3 until pH 11
- add CH2Cl2
- partition
- drying
- evaporation
Scheme 6.2: Extraction of leaves.
CH2Cl2 crude
Aqueous layer Organic layer
Aqueous layer Organic layer
CH2Cl2 crude after
acid-base extraction
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Table 6.2: Amount of each plant material used for extraction and percentage yield of the
crudes.
Plant material Part of
plant
Amount Yield of crude (g) Percentage yield
(%)
N. officinalis -
Madek
Bark 2.0 kg Hexane- 3.83
CH2Cl2- 11.00
MeOH- 23.62
Hexane- 0.19
CH2Cl2- 0.55
MeOH- 1.18
Leaves 1.9 kg Hexane- 21.80
*CH2Cl2- 1.54
MeOH- 57.39
Hexane- 1.15
CH2Cl2- 0.08
MeOH- 3.02
N. officinalis -
Mersing
Bark 1.5 kg Hexane- 2.17
CH2Cl2-6.24
MeOH- 18.02
Hexane- 0.14
CH2Cl2- 0.42
MeOH- 1.20
Leaves 1.3 kg Hexane- 19.16
*CH2Cl2- 3.54
MeOH- 37.05
Hexane- 1.47
CH2Cl2- 0.27
MeOH- 2.85
N. subdita Bark 1.7 kg Hexane- 1.66
CH2Cl2- 5.81
MeOH- 26.45
Hexane- 0.10
CH2Cl2- 0.34
MeOH- 1.56
Leaves 2.0 kg Hexane- 16.82
*CH2Cl2- 1.13
MeOH- 34.72
Hexane- 0.84
CH2Cl2- 0.06
MeOH- 1.74
*Weight of crude after acid-base extraction
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6.8 Isolation and Purification
The CH2Cl2 crude was subjected to column chromatography using silica gel 60
as the stationary phase. The solvent used was CH2Cl2 with increasing portion of MeOH
(gradient elution system). Solvent systems used for for column chromatography
separation of CH2Cl2 crude of N. officinalis (Madek and Mersing) and N. subdita were
shown in Table 6.3.
Table 6.3: Solvent system for the isolation and purification of the CH2Cl2 crude of bark
and leaves of N. officinalis (Madek and Mersing) and N. subdita.
Dichloromethane (CH2Cl2) Methanol (MeOH)
100 0
99 1
98 2
97 3
96 4
95 5
94 6
90 10
83 17
75 25
0 100
The fractions which were collected were monitored using TLC and those with
the same TLC profile were combined which were later subjected to column
chromatography or preparative TLC in order to isolate and purify compounds. For the
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MeOH crude of leaves of N. officinalis (Madek), HPLC was used for the isolation and
purification of compounds. The solvent system applied is shown in Table 6.4.
Table 6.4: Solvent system for the purification of the MeOH crude of the leaves of N.
officinalis (Madek)
Time (min) Flow rate (mL/min) %A2 (H2O + FA) %B2 (MeOH + FA)
0 3 70 30
2 3 70 30
32 3 0 100
35 3 0 100
37 3 70 30
40 3 70 30
The structures of the isolated compounds were elucidated with the aid of
spectroscopic methods such as 1D NMR (1H, 13C, DEPT), 2D NMR (COSY, HMBC,
HMQC/HSQC, NOESY), UV, IR and ESIMS/LCMS-IT-TOF. The optical rotations for
the optically active compounds were also determined.
The isolated compounds from the bark and leaves of N. officinalis (Madek), N.
officinalis (Mersing) and N. subdita are listed in Table 6.5 - Table 6.10. The isolation
and purification of the compounds from these species are shown in Scheme 6.3- Scheme
6.11.
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Table 6.5: Compounds isolated from the bark of N. officinalis (Madek) and their
chromatography solvent systems.
Compounds Type of crude Solvent system Weight (mg)
Stigmast-4-en-3-one 57 Hexane 80:20 (Hexane:CH2Cl2) 2.2
Vanillin 58 CH2Cl2 100:0 (CH2Cl2:MeOH) 3.0
Cinnamide 59 CH2Cl2 99:1 (CH2Cl2:MeOH) 2.4
1,2,3,4-tetrahydro-1-oxo-
β-carboline
60
CH2Cl2 99.1 (CH2Cl2:MeOH) 4.1
Naucletine 61 CH2Cl2 99:1 (CH2Cl2:MeOH) 11.8
Angustine 42 CH2Cl2 98:2 (CH2Cl2 :MeOH) 15.2
Benzamide 62 CH2Cl2 98:2 (CH2Cl2 :MeOH) 2.3
Angustidine 44 CH2Cl2 98:2 (CH2Cl2 :MeOH) 5.5
Nauclefine 63 CH2Cl2 98:2 (CH2Cl2 :MeOH) 8.5
Naucline 56 CH2Cl2 97:3 (CH2Cl2 :MeOH) 12.8
Angustoline 43 CH2Cl2 97:3 (CH2Cl2 :MeOH) 4.6
Table 6.6: Compounds isolated from the leaves of N. officinalis (Madek) and their
chromatography solvent systems.
Compounds Type of crude Solvent system Weight (mg)
Angustine 42 CH2Cl2 97:3 (CH2Cl2 :MeOH) 4.1
Blumenol A 66 CH2Cl2 97:3 (CH2Cl2 :MeOH) 3.5
Harmane 67 CH2Cl2 96:4 (CH2Cl2 :MeOH) 3.2
3,14-dihydroangustoline
68
CH2Cl2 95:5 (CH2Cl2 :MeOH) 2.3
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Pumiloside 69 MeOH (MeOH:H2O - HPLC) 5.7
Strictosamide 70 MeOH (MeOH:H2O - HPLC) 6.4
Table 6.7: Compounds isolated from the bark of N. officinalis (Mersing) and their
chromatography solvent systems.
Compounds Type of crude Solvent system Weight (mg)
Naucleficine 64 CH2Cl2 100:0 (CH2Cl2:MeOH) 5.2
Naucleactonin C 65 CH2Cl2 100:0 (CH2Cl2:MeOH) 2.4
Angustine 42 CH2Cl2 98:2 (CH2Cl2:MeOH) 7.2
Angustidine 44 CH2Cl2 97:3 (CH2Cl2:MeOH) 4.3
Nauclefine 63 CH2Cl2 97:3 (CH2Cl2:MeOH) 6.1
Table 6.8: Compounds isolated from the leaves of N. officinalis (Mersing) and their
chromatography solvent systems.
Compounds Type of crude Solvent system Weight (mg)
Benzamide 62 CH2Cl2 99:1 (CH2Cl2:MeOH) 2.5
Angustine 42 CH2Cl2 98:2 (CH2Cl2:MeOH) 4.2
Nauclefine 63 CH2Cl2 97:3 (CH2Cl2:MeOH) 2.9
Blumenol B 71 CH2Cl2 97:3 (CH2Cl2:MeOH) 2.7
Blumenol A 66 CH2Cl2 97:3 (CH2Cl2:MeOH) 3.3
Angustoline 43 CH2Cl2 96:4 (CH2Cl2:MeOH) 3.1
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Table 6.9: Compounds isolated from the bark of N. subdita and their chromatography
solvent systems.
Compounds Type of crude Solvent system Weight (mg)
Stigmast-4-en-3-one 57 Hexane 80:20 (Hexane:CH2Cl2) 3.7
β-sitosterol 73 Hexane 80:20 (Hexane:CH2Cl2) 2.5
Naucleactonin C 65 CH2Cl2 100:0 (CH2Cl2:MeOH) 2.3
Subditine 72 CH2Cl2 98:2 (CH2Cl2:MeOH) 18.1
Benzamide 62 CH2Cl2 98:2 (CH2Cl2:MeOH) 4.6
Cinnamide 59 CH2Cl2 98:2 (CH2Cl2:MeOH) 2.2
1,2,3,4-tetrahydro-1-oxo-
β-carboline 60
CH2Cl2 98:2 (CH2Cl2:MeOH) 3.4
Angustine 42 CH2Cl2 98:2 (CH2Cl2:MeOH) 20.7
Angustidine 44 CH2Cl2 97:3 (CH2Cl2:MeOH) 8.1
Nauclefine 63 CH2Cl2 97:3 (CH2Cl2:MeOH) 10.5
Harmane 67 CH2Cl2 96:4 (CH2Cl2:MeOH) 2.7
Angustoline 43 CH2Cl2 96:4 (CH2Cl2:MeOH) 8.2
Table 6.10: Compounds isolated from the leaves of N. subdita and their chromatography
solvent systems.
Compounds Type of crude Solvent system Weight (mg)
Angustine 42 CH2Cl2 98:2 (CH2Cl2:MeOH) 3.1
Harmane 67 CH2Cl2 96:4 (CH2Cl2:MeOH) 2.5
Chapter 6: Experimental
270
Scheme 6.3: Isolation and purification of compounds from the hexane crude of the bark
of N. officinalis from Madek.
N. officinalis (Madek)
(Bark 2.0 kg)
Hexane crude
(3.83 g)
Hexane crude used for
purification
(31.6 mg)
PTLC
Stigmast-4-en-3-one 57
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Scheme 6.4: Isolation and purification of the compounds from the CH2Cl2 crude of the
bark of N. officinalis from Madek.
Fractions
9-27
CH2Cl2 crude
(11.00 g)
CC (CH2Cl2 :MeOH)
Fractions
131-156
Fractions
157-204
Fractions
329-348
Fractions
92-130
Fractions
277-298
Fractions
349-400
Vanillin 58
1,2,3,4-tetrahydro-1-
oxo-β-carboline 60
Cinnamide 59
Naucletine 61
Angustine 42
Nauclefine 63
PTLC
Angustidine 44
PTLC
Naucline 56
Benzamide 62
PTLC
PTLC
PTLC PTLC
Angustoline 43
PTLC
N. officinalis (Madek)
(Bark 2.0 kg)
Naucline 56
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Scheme 6.5: Isolation and purification of the compounds from the CH2Cl2 crude of the
leaves of N. officinalis from Madek.
CH2Cl2 extract
(29.44 g)
CH2Cl2 crude
(1.54 g)
26.27 g used for
acid-base extraction
Fractions
92-116
Fractions
135-144
Angustine
42
3,14-dihydroangustoline 68
PTLC PTLC
Blumenol A
66
Harmane 67
Fractions
117-126
N. officinalis (Madek)
(Leaves 1.9 kg)
CC (CH2Cl2 :MeOH)
PTLC
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Scheme 6.6: Isolation and purification of the compounds from the MeOH crude of the
leaves of N. officinalis from Madek
N. officinalis (Madek)
(Leaves 1.9 kg)
MeOH crude
(57.39 g)
70 mg of crude was
injected into HPLC
Pumiloside 69 Strictosamide 70
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HPLC :Prep (Waters)
Column : C18 reversed phase (5 μM)
Column brand : X-bridge
Column size : 10 X 150 mm
Injection volume : 200 μL per injection
Retention time : 17.22 min - Pumiloside 69
23.64 min – Strictosamide 70
Figure 6.1: Chromatogram of isolated compounds; pumiloside 69 and strictosamide 70
at retention time of 17.22 min and 23.64 min respectively.
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Scheme 6.7: Isolation and purification of the compounds from the CH2Cl2 crude of the
bark of N. officinalis from Mersing.
CH2Cl2 crude
(6.24 g)
4.58 g for CC
(CH2Cl2 :MeOH)
Fractions
6-9
Fractions
25
Fractions
28-29
Fractions
30
PTLC
Naucleficine
64
Naucleactonin C
65
Angustine
42
PTLC PTLC
Angustidine
44
Nauclefine
63
PTLC
N. officinalis (Mersing)
(Bark 1.5 kg)
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Scheme 6.8: Isolation and purification of the compounds from the CH2Cl2 crude of the
leaves of N. officinalis from Mersing.
CH2Cl2 extract
(24.82 g)
CH2Cl2 crude
(3.54 g)
21.73 g used for
acid-base extraction
N. officinalis (Mersing)
(Leaves 1.3 kg)
Fractions
25-28
Fractions
33-40
Fractions
41-45
Fractions
74-78
Benzamide
62
Nauclefine
63
Blumenol A
66
Blumenol B
71
Angustine
42
Angustoline
43
PTLC PTLCPTLCPTLC
CC (CH2Cl2 :MeOH)
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Scheme 6.9: Isolation and purification of the compounds from the heaxane crude of the
bark of N. subdita.
Hexane crude
(1.66 g)
Hexane crude used for
purification
(51.3 mg)
PTLC
Stigmast-4-en-3-one 57 β-sitosterol 73
N. subdita
(Bark 1.7 kg)
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Scheme 6.10: Isolation and purification of the compounds from the CH2Cl2 crude of the
bark of N. subdita.
Fractions
8-15
CH2Cl2 crude
(5.81 g)
CC (CH2Cl2 :MeOH)
Fractions
121-140
Fractions
84-120
Fractions
153-166
Fractions
37-83
Naucleactonin C
65
1,2,3,4-tetrahydro-1-
oxo-β-carboline 60
Cinnamide 59
Harmane 67
Angustine 42
Nauclefine 63
PTLC
Angustidine 44
PTLC
Subditine 72
Benzamide 62
PTLC
PTLC
PTLC PTLC
Fractions
199-216
Angustoline 43
Nauclea subdita
(Bark 1.7 kg)
Subditine 72
Angustine 42
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Scheme 6.11: Isolation and purification of the compounds from the CH2Cl2 crude of the
leaves of N. subdita.
CH2Cl2 extract
(20.40 g)
CH2Cl2 crude
(1.13 g)
18.72 g used for
acid-base extraction
Fractions
57-62
Fractions
63-68
CC (CH2Cl2 :MeOH)
Angustine 42 Harmane 67
PTLC PTLC
N. subdita
(Leaves 2.0 kg)
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6.9 Physical and Spectral Data of Isolated Compounds
Naucline 56 : Brownish amorphous solid
Molecular formula : C20H18N2O2
UV λmax, nm : 391, 374, 214
IR vmax (NaCl), cm-1 : 1638
Mass spectrum m/z : 319.1450 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.2
13C NMR (CDCl3) δ ppm : See Table 3.2
Nauclefine 63 : Yellowish amorphous solid
Molecular formula : C18H13N3O
UV λmax, nm : 391, 372, 220, 204
IR vmax (NaCl), cm-1 : 3415, 1650
Mass spectrum m/z : 288.1155 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.3
13C NMR (CDCl3) δ ppm : See Table 3.3
Naucletine 61 : Yellowish amorphous solid
Molecular formula : C20H15N3O2
UV λmax, nm : 402, 312, 260, 210
IR vmax (NaCl), cm-1 : 1675, 1653
Mass spectrum m/z : 330.1266 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.4
13C NMR (CDCl3) δ ppm : See Table 3.4
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Angustine 42 : Orange amorphous solid
Molecular formula : C20H15N3O
UV λmax, nm : 399, 381, 305, 293, 210
IR vmax (NaCl), cm-1 : 3425, 1645
Mass spectrum m/z : 314.1361 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.5
13C NMR (CDCl3) δ ppm : See Table 3.5
Angustoline 43 : Orange amorphous solid
Molecular formula : C20H17N3O2[α] : -72.7º (c 0.1, CHCl3)
UV λmax, nm : 394, 375, 210
IR vmax (NaCl), cm-1 : 1653, 1103
Mass spectrum m/z : 332.1096 ([M+H]+
1H NMR (C5D5N) δ ppm : See Table 3.6
13C NMR (C5D5N) δ ppm : See Table 3.6
3,14-dihydroangustoline 68 : Yellowish amorphous solid
Molecular formula : C20H19N3O2[α] : -88.9º (c 0.09, CHCl3)
UV λmax, nm : 393, 375, 219
IR vmax (NaCl), cm-1 : 1640, 1101
Mass spectrum m/z : 334.1267 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.7
13C NMR (CDCl3) δ ppm : See Table 3.7
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Angustidine 44 : Orange amorphous solid
Molecular formula : C19H15N3O
UV λmax, nm : 391, 288, 229
IR vmax (NaCl), cm-1 : 3401, 1644
Mass spectrum m/z : 302.1317 ([M+H]+)
1H NMR (C5D5N) δ ppm : See Table 3.8
13C NMR (C5D5N) δ ppm : See Table 3.8
Subditine 72 : Yellowish amorphous solid
Molecular formula : C20H15N3O2
UV λmax, nm : 393, 377, 210
IR vmax (NaCl), cm-1 : 3305, 1645
Mass spectrum m/z : 330.1018 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.9
13C NMR (CDCl3) δ ppm : See Table 3.9
Strictosamide 70 : Light yellowish amorphous solid
Molecular formula : C26H30N2O8[α] : -40.0º (c 0.1, MeOH)
UV λmax, nm : 387, 328, 225, 203
IR vmax (NaCl), cm-1 : 1653, 1050
Mass spectrum m/z : 512.1875 ([M+Na]+)
1H NMR (CD3OD) δ ppm : See Table 3.10
13C NMR (CD3OD) δ ppm : See Table 3.10
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Pumiloside 69 : Light yellowish amorphous solid
Molecular formula : C26H28N2O9[α] : -93.5º (c 0.31, MeOH)
UV λmax, nm : 328, 314, 244, 210
IR vmax (NaCl), cm-1 : 3415, 1653
Mass spectrum m/z : 535.1649 ([M+Na]+)
1H NMR (DMF-d7) δ ppm : See Table 3.11
13C NMR (DMF-d7) δ ppm : See Table 3.11
Naucleficine 64 : Orange amorphous solid
Molecular formula : C20H14N2O2
UV λmax, nm : 379, 364, 298, 263, 229
IR vmax (NaCl), cm-1 : 3271, 1676, 1642
Mass spectrum m/z : 315.1126 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.12
13C NMR (CDCl3) δ ppm : See Table 3.12
Naucleactonin C 65 : Yellowish amorphous solid
Molecular formula : C19H14N2O2
UV λmax, nm : 368, 353, 211
IR vmax (NaCl), cm-1 : 3281, 1653
Mass spectrum m/z : 303.1127 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.13
13C NMR (CDCl3) δ ppm : See Table 3.13
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Harmane 67 : Brownish amorphous solid
Molecular formula : C12H10N2
UV λmax, nm : 348, 288, 233
IR vmax (NaCl), cm-1 : 3145
Mass spectrum m/z : 183.0942 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.14
13C NMR (CDCl3) δ ppm : See Table 3.14
1,2,3,4-tetrahydro-1-oxo-β-carboline 60 : Brownish amorphous solid
Molecular formula : C11H10N2O
UV λmax, nm : 298, 240
IR vmax (NaCl), cm-1 : 3415, 1734
Mass spectrum m/z : 187.9447 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.15
13C NMR (CDCl3) δ ppm : See Table 3.15
Benzamide 62 : Light yellowish armorphous solid
Molecular formula : C7H7NO
UV λmax, nm : 222
IR vmax (NaCl), cm-1 : 3390, 3187
Mass spectrum m/z : 122.0601 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.16
13C NMR (CDCl3) δ ppm : See Table 3.16
Cinnamide 59 : Light yellowish amorphous solid
Molecular formula : C9H9NO
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UV λmax, nm : 272, 217
IR vmax (NaCl), cm-1 : 3369, 3172
Mass spectrum m/z : 148.0750 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.17
13C NMR (CDCl3) δ ppm : See Table 3.17
Blumenol B 71 : White amorphous solid
Molecular formula : C13H22O3[α] : +36.4º (c 0.11, CHCl3)
UV λmax, nm : 242
IR vmax (NaCl), cm-1 : 3401, 1651, 1126
Mass spectrum m/z : 227.1733 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.18
13C NMR (CDCl3) δ ppm : See Table 3.18
Blumenol A 66 : White amorphous solid
Molecular formula : C13H20O3[α] : +146.6º (c 0.58, CHCl3)
UV λmax, nm : 237
IR vmax (NaCl), cm-1 : 3402, 1655, 1124
Mass spectrum m/z : 225.1665 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.19
13C NMR (CDCl3) δ ppm : See Table 3.19
β-sitosterol 73 : White amorphous solid
Molecular formula : C29H50O
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[α] : -55.6º (c 0.09, CHCl3)
UV λmax, nm : 203
IR vmax (NaCl), cm-1 : 3425, 2925, 1465, 1375
Mass spectrum m/z : 415.3561 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.20
13C NMR (CDCl3) δ ppm : See Table 3.20
Stigmast-4-en-3-one 57 : White amorphous solid
Molecular formula : C29H48O[α] : +75.0º (c 0.12, CHCl3)
UV λmax, nm : 241
IR vmax (NaCl), cm-1 : 1675, 1468, 1375
Mass spectrum m/z : 413.2660 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.21
13C NMR (CDCl3) δ ppm : See Table 3.21
Vanillin 58 : Light brownish amorphous solid
Molecular formula : C8H8O3
UV λmax, nm : 308, 277
IR vmax (NaCl), cm-1 : 3365, 1661, 1155
Mass spectrum m/z : 153.0555 ([M+H]+)
1H NMR (CDCl3) δ ppm : See Table 3.22
13C NMR (CDCl3) δ ppm : See Table 3.22
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